Jack L. Strominger

Jack L. Strominger's AcademicInfluence.com Rankings

Jack L. Strominger

Biology

#668

World Rank

#1174

Historical Rank

#371

USA Rank

Biochemistry

#50

World Rank

#65

Historical Rank

#33

USA Rank

biology Degrees

Download Badge

Biology

Jack L. Strominger's Degrees

PhD Biochemistry University of California, Berkeley

Why Is Jack L. Strominger Influential?

(Suggest an Edit or Addition)

According to Wikipedia, Jack Leonard Strominger is the Higgins Professor of Biochemistry at Harvard University, specializing in the structure and function of human histocompatibility proteins and their role in disease. He won the Albert Lasker Award for Basic Medical Research in 1995.

(See a Problem?)

Jack L. Strominger's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Structure of the human class I histocompatibility antigen, HLA-A2 (1987) (3124)
Nomenclature for factors of the HLA system, 2010 (2010) (2496)
The foreign antigen binding site and T cell recognition regions of class I histocompatibility antigens (1987) (2338)
Three-dimensional structure of the human class II histocompatibility antigen HLA-DR1 (1993) (2278)
Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide (1994) (1567)
Molecular mimicry in T cell-mediated autoimmunity: Viral peptides activate human T cell clones specific for myelin basic protein (1995) (1567)
Recognition of haemagglutinins on virus-infected cells by NKp46 activates lysis by human NK cells (2001) (1039)
Specificity and promiscuity among naturally processed peptides bound to HLA-DR alleles (1993) (940)
Identification of a putative second T-cell receptor (1986) (930)
The selective downregulation of class I major histocompatibility complex proteins by HIV-1 protects HIV-infected cells from NK cells. (1999) (927)
Epstein-Barr virus receptor of human B lymphocytes is the C3d receptor CR2. (1984) (916)
Mechanism of action of penicillins: a proposal based on their structural similarity to acyl-D-alanyl-D-alanine. (1965) (848)
Interaction between CD4 and class II MHC molecules mediates cell adhesion (1987) (822)
Human Decidual Natural Killer Cells Are a Unique NK Cell Subset with Immunomodulatory Potential (2003) (820)
Predominant naturally processed peptides bound to HLA-DR1 are derived from MHC-related molecules and are heterogeneous in size (1992) (747)
Three distinct antigens associated with human T-lymphocyte-mediated cytolysis: LFA-1, LFA-2, and LFA-3. (1982) (742)
Toll-like Receptor 2 (TLR2) and TLR4 Differentially Activate Human Dendritic Cells* (2001) (741)
The three-dimensional structure of HLA-B27 at 2.1 Å resolution suggests a general mechanism for tight peptide binding to MHC (1992) (693)
The structure of HLA-B27 reveals nonamer self-peptides bound in an extended conformation (1991) (683)
Specificity pockets for the side chains of peptide antigens in HLA-Aw68 (1990) (662)
Extreme Th1 bias of invariant Vα24JαQ T cells in type 1 diabetes (1998) (644)
The class II molecules of the human and murine major histocompatibility complex (1984) (614)
Three-dimensional structure of a human class II histocompatibility molecule complexed with superantigen (1994) (595)
Penicillin-binding proteins and the mechanism of action of beta-lactam antibiotics. (1983) (548)
Immune interferon activates multiple class II major histocompatibility complex genes and the associated invariant chain gene in human endothelial cells and dermal fibroblasts. (1984) (530)
Protection from Natural Killer Cell-Mediated Lysis by HLA-G Expression on Target Cells (1996) (528)
Human lymphocytes bearing T cell receptor gamma/delta are phenotypically diverse and evenly distributed throughout the lymphoid system (1989) (505)
Enzymes that degrade bacterial cell walls (1966) (504)
Evidence for extrathymic changes in the T cell receptor gamma/delta repertoire (1990) (482)
HLA-C is the inhibitory ligand that determines dominant resistance to lysis by NK1- and NK2-specific natural killer cells. (1993) (467)
Recombinant human tumor necrosis factor increases mRNA levels and surface expression of HLA-A,B antigens in vascular endothelial cells and dermal fibroblasts in vitro. (1986) (464)
Shedding as a mechanism of down-modulation of CD14 on stimulated human monocytes. (1991) (453)
Two genes encoding steroid 21-hydroxylase are located near the genes encoding the fourth component of complement in man. (1985) (444)
Different length peptides bind to HLA-Aw68 similarly at their ends but bulge out in the middle (1992) (439)
Major histocompatibility antigens: The human (HLA-A,-B,-C) and murine (H-2K, H-2D) class I molecules (1981) (437)
Characterization of a monoclonal antibody (4F2) that binds to human monocytes and to a subset of activated lymphocytes. (1981) (433)
Nomenclature for factors of the HLA system, 2004 (2005) (431)
The human natural killer cell immune synapse. (1999) (426)
Glycoproteins of 210,000 and 130,000 m.w. on activated T cells: cell distribution and antigenic relation to components on resting cells and T cell lines. (1984) (403)
Immune mechanisms at the maternal-fetal interface: perspectives and challenges (2015) (398)
MHC class II proteins and disease: a structural perspective (2006) (393)
Composition of the cell wall of Staphylococcus aureus: its relation to the mechanism of action of penicillin. (1959) (388)
NK3-specific natural killer cells are selectively inhibited by Bw4- positive HLA alleles with isoleucine 80 (1994) (383)
Structure of the human class I histocompatibility antigen, HLA-A2. (2005) (377)
A self-assembled monolayer for the binding and study of histidine-tagged proteins by surface plasmon resonance. (1996) (376)
Protection from lysis by natural killer cells of group 1 and 2 specificity is mediated by residue 80 in human histocompatibility leukocyte antigen C alleles and also occurs with empty major histocompatibility complex molecules (1996) (373)
Kinetics and peptide dependency of the binding of the inhibitory NK receptor CD94/NKG2‐A and the activating receptor CD94/NKG2‐C to HLA‐E (1999) (370)
Mode of Action of Penicillin Biochemical Basis for the Mechanism of Action of Penicillin and for Its Selective Toxicity (1957) (350)
A humanized model for multiple sclerosis using HLA-DR2 and a human T-cell receptor (1999) (346)
Structural requirements for binding of an immunodominant myelin basic protein peptide to DR2 isotypes and for its recognition by human T cell clones (1994) (345)
The class I MHC homologue of human cytomegalovirus inhibits attack by natural killer cells (1997) (344)
TGFβ promotes conversion of CD16+ peripheral blood NK cells into CD16− NK cells with similarities to decidual NK cells (2007) (340)
Linkage map of the human major histocompatibility complex including the tumor necrosis factor genes. (1987) (336)
Activation of CD1d-restricted T cells protects NOD mice from developing diabetes by regulating dendritic cell subsets (2001) (332)
Developmental plasticity of CNS microglia (2001) (323)
Distribution of Ia-like molecules on the surface of normal and leukemic human cells. (1976) (323)
Characterization of the cell surface heterodimer VLA-4 and related peptides. (1987) (321)
Mechanism of action of bacitracin: complexation with metal ion and C 55 -isoprenyl pyrophosphate. (1971) (321)
Human decidual NK cells form immature activating synapses and are not cytotoxic (2005) (316)
THE SMALL SUBUNIT OF HL-A ANTIGENS IS β2-MICROGLOBULIN (1973) (315)
p62, a Phosphotyrosine-independent Ligand of the SH2 Domain of p56lck, Belongs to a New Class of Ubiquitin-binding Proteins* (1996) (315)
Simultaneous flow cytometric analysis of human T cell activation antigen expression and DNA content (1983) (308)
Wiskott–Aldrich syndrome protein is required for NK cell cytotoxicity and colocalizes with actin to NK cell-activating immunologic synapses (2002) (306)
Toxic shock syndrome toxin-1 complexed with a class II major histocompatibility molecule HLA-DR1. (1994) (297)
Cross-linking of human T cell receptor proteins: association between the T cell idiotype β subunit and the T3 glycoprotein heavy subunit (1985) (293)
Interaction of penicillin with the bacterial cell: penicillin-binding proteins and penicillin-sensitive enzymes. (1974) (283)
Genes for the tumor necrosis factors alpha and beta are linked to the human major histocompatibility complex. (1986) (276)
Human CD16 as a lysis receptor mediating direct natural killer cell cytotoxicity. (1999) (274)
Enzymatic formation of uridine diphosphoglucuronic acid. (1957) (272)
Human class II major histocompatibility complex genes and proteins. (1988) (268)
Biochemical characterization of a soluble form of the 53‐kDa monocyte surface antigen (1986) (263)
Nomenclature for Factors of the HLA System, 1995 (1995) (262)
Nomenclature for Factors of the HLA System, 1991 (1992) (259)
Purification and characterization of a prokaryotic glycoprotein from the cell envelope of Halobacterium salinarium. (1976) (259)
Two Unique Human Decidual Macrophage Populations (2011) (257)
Purification and properties of C 55 -isoprenoid alcohol phosphokinase from Staphylococcus aureus. (1972) (256)
Atomic structure of a human MHC molecule presenting an influenza virus peptide (1992) (250)
IL-10 Released by Concomitant TLR2 Stimulation Blocks the Induction of a Subset of Th1 Cytokines That Are Specifically Induced by TLR4 or TLR3 in Human Dendritic Cells1 (2004) (249)
Viral evasion of natural killer cells (2002) (247)
Generation of allospecific natural killer cells by stimulation across a polymorphism of HLA-C. (1993) (246)
Peptide binding to HLA‐DR1: a peptide with most residues substituted to alanine retains MHC binding. (1990) (245)
Nomenclature for factors of the HLA system, 1996. (1997) (244)
Crystallographic analysis of endogenous peptides associated with HLA-DR1 suggests a common, polyproline II-like conformation for bound peptides. (1996) (240)
CD1d-Restricted NKT Cells Express a Chemokine Receptor Profile Indicative of Th1-Type Inflammatory Homing Cells 1 (2003) (239)
Structural basis for major histocompatibility complex (MHC)-linked susceptibility to autoimmunity: charged residues of a single MHC binding pocket confer selective presentation of self-peptides in pemphigus vulgaris. (1995) (230)
Biosynthesis of the peptidoglycan of bacterial cell walls. 8. Peptidoglycan transpeptidase and D-alanine carboxypeptidase: penicillin-sensitive enzymatic reaction in strains of Escherichia coli. (1968) (228)
Long-term human cytolytic T-cell lines allospecific for HLA-DR6 antigen are OKT4+. (1982) (227)
Promoter switching in Epstein-Barr virus during the initial stages of infection of B lymphocytes. (1990) (227)
HLA‐DR Antigens: Structure, Separation of Subpopulations, Gene Cloning and Function (1982) (226)
Assembly and maturation of HLA-A and HLA-B antigens in vivo (1979) (225)
A new cluster of genes within the human major histocompatibility complex. (1989) (223)
Allelic variants of the human putative peptide transporter involved in antigen processing. (1992) (222)
Transcription factor B cell lineage-specific activator protein regulates the gene for human X-box binding protein 1 (1996) (222)
Purification and characterization of class II histocompatibility antigens from a homozygous human B cell line. (1987) (221)
Nomenclature for factors of the HLA system, 2002. (2002) (220)
Characterization of a monoclonal antibody (5E9) that defines a human cell surface antigen of cell activation. (1981) (217)
Developmental biology of T cell receptors. (1989) (216)
Nomenclature for Factors of the HLA System, 1994 (1994) (214)
Selective binding of self peptides to disease-associated major histocompatibility complex (MHC) molecules: a mechanism for MHC-linked susceptibility to human autoimmune diseases (1995) (214)
Bacitracin: an inhibitor of the dephosphorylation of lipid pyrophosphate, an intermediate in the biosynthesis of the peptidoglycan of bacterial cell walls. (1967) (214)
Disulfide bond-mediated dimerization of HLA-G on the cell surface (2002) (214)
Isotypic and allotypic variation of human class II histocompatibility antigen α-chain genes (1984) (212)
Differential binding to HLA-C of p50-activating and p58-inhibitory natural killer cell receptors. (1998) (212)
Isolation and immunologic characterization of a human. B-lymphocyte- specific, cell surface antigen (1976) (211)
Extracellular antigen processing and presentation by immature dendritic cells. (1999) (211)
LIPID-PHOSPHOACETYLMURAMYL-PENTAPEPTIDE AND LIPID-PHOSPHODISACCHARIDE-PENTAPEPTIDE: PRESUMED MEMBRANE TRANSPORT INTERMEDIATES IN CELL WALL SYNTHESIS. (1965) (209)
Extreme Th1 bias of invariant Valpha24JalphaQ T cells in type 1 diabetes. (1998) (209)
Genetic Complexity and Expression of Human Class II Histocompatibility Antigens (1985) (207)
CD151 accelerates breast cancer by regulating alpha 6 integrin function, signaling, and molecular organization. (2008) (206)
Biosynthesis of the peptidoglycan of bacterial cell walls. I. Utilization of uridine diphosphate acetylmuramyl pentapeptide and uridine diphosphate acetylglucosamine for peptidoglycan synthesis by particulate enzymes from Staphylococcus aureus and Micrococcus lysodeikticus. (1966) (206)
Identification of a novel cyclosporin-sensitive element in the human tumor necrosis factor alpha gene promoter (1993) (205)
Human (HLA-A and HLA-B) and murine (H-2K and H-2D) histocompatibility antigens are cell surface receptors for Semliki Forest virus. (1978) (203)
Structure of a lipid intermediate in cell wall peptidoglycan synthesis: a derivative of a C55 isoprenoid alcohol. (1967) (201)
NK cytotoxicity against CD4+ T cells during HIV-1 infection: a gp41 peptide induces the expression of an NKp44 ligand. (2005) (199)
Isolation of complementary DNA clones encoding the human lymphocyte glycoprotein T1/Leu-1 (1986) (199)
CD1d and invariant NKT cells at the human maternal–fetal interface (2002) (196)
Germ line deletion of the CD1 locus exacerbates diabetes in the NOD mouse (2001) (196)
Nomenclature for Factors of the HLA System, 2004. (2005) (194)
Recognition of the immunodominant myelin basic protein peptide by autoantibodies and HLA-DR2-restricted T cell clones from multiple sclerosis patients. Identity of key contact residues in the B-cell and T-cell epitopes. (1997) (193)
Expression of human class II major histocompatibility complex antigens using retrovirus vectors. (1987) (190)
Suppression of in vitro Epstein-Barr virus infection. A new role for adult human T lymphocytes (1977) (189)
Immunological identity of the small subunit of HL-A antigens and beta2-microglobulin and its turnover on the cell membrane. (1974) (188)
Deficient natural killer cell cytotoxicity in patients with IKK-γ/NEMO mutations (2002) (187)
Molecular cloning of a phosphotyrosine-independent ligand of the p56lck SH2 domain. (1996) (186)
Characterization of a novel differentiation antigen complex recognize by a monoclonal antibody (A-1A5): unique activation-specific molecular forms on stimulated T cells. (1983) (184)
Mechanisms of Enzymatic Bacteriolysis (1967) (184)
The mature activating natural killer cell immunologic synapse is formed in distinct stages. (2004) (184)
Cell-free translation of the mRNAs for the heavy and light chains of HLA-A and HLA-B antigens. (1979) (183)
Staphylococcal enterotoxin A has two cooperative binding sites on major histocompatibility complex class II (1995) (181)
Metalloprotease and serine protease are involved in cleavage of CD43, CD44, and CD16 from stimulated human granulocytes. Induction of cleavage of L-selectin via CD16. (1994) (180)
HUMAN LYMPHOCYTES BEARING T CELL RECEPTOR Y / S ARE PHENOTYPICALLY DIVERSE AND EVENLY DISTRIBUTED THROUGHOUT THE LYMPHOID SYSTEM (179)
HLA-G homodimer-induced cytokine secretion through HLA-G receptors on human decidual macrophages and natural killer cells (2009) (177)
ENZYMATIC OXIDATION OF URIDINE DIPHOSPHATE GLUCOSE TO URIDINE DIPHOSPHATE GLUCURONIC ACID (1954) (176)
Human B-cell alloantigens DC1, MT1, and LB12 are identical to each other but distinct from the HLA-DR antigen. (1981) (175)
A subset of HLA-B27 molecules contains peptides much longer than nonamers. (1994) (174)
HLA-G: At the Interface of Maternal-Fetal Tolerance. (2017) (171)
Alloantigen recognition by two human natural killer cell clones is associated with HLA-C or a closely linked gene. (1992) (169)
Redefining the Epstein-Barr virus-encoded nuclear antigen EBNA-1 gene promoter and transcription initiation site in group I Burkitt lymphoma cell lines. (1995) (168)
Characterization of a monoclonal antibody that defines an immunoregulatory T cell subset for immunoglobulin synthesis in humans. (1980) (167)
Variations in regulation of energy exchange associated with estrus, diestrus and pseudopregnancy in rats. (1947) (164)
Two putative subunits of a peptide pump encoded in the human major histocompatibility complex class II region. (1991) (164)
Role for the Epstein-Barr virus nuclear antigen 2 in viral promoter switching during initial stages of infection. (1991) (162)
Generation of hypoimmunogenic human pluripotent stem cells (2019) (162)
Nomenclature for Factors of the HLA System, 1998 (1999) (160)
Glycopeptide transpeptidase and D-alanine carboxypeptidase: penicillin-sensitive enzymatic reactions. (1966) (157)
COMPETITIVE INHIBITION OF ENZYMATIC REACTIONS BY OXAMYCIN (1960) (157)
Complex formation between bacitracin peptides and isoprenyl pyrophosphates. The specificity of lipid-peptide interactions. (1973) (157)
Human tumor necrosis factor alpha gene regulation in phorbol ester stimulated T and B cell lines (1991) (153)
Nomenclature for factors of the HLA system, 1998. (1999) (152)
Macaques immunized with HLA-DR are protected from challenge with simian immunodeficiency virus (1995) (150)
Structure of the peptidoglycan from spores of Bacillus subtilis. (1972) (150)
The γδT Cell Receptor (1988) (149)
Enzymatic sulfation of mucopolysaccharides in hen oviduct. I. Transfer of sulfate from 3'-phosphoadenosine 5'-phosphosulfate to mucopolysaccharides. (1960) (149)
Crystal structure of HLA-DQ0602 that protects against type 1 diabetes and confers strong susceptibility to narcolepsy (2004) (149)
STRUCTURE OF THE CELL WALL OF STAPHYLOCOCCUS AUREUS, STRAIN COPENHAGEN. I. PREPARATION OF FRAGMENTS BY ENZYMATIC HYDROLYSIS. (1963) (148)
Many NK cell receptors activate ERK2 and JNK1 to trigger microtubule organizing center and granule polarization and cytotoxicity (2007) (147)
Specific complex formation between the type II bare lymphocyte syndrome-associated transactivators CIITA and RFX5. (1997) (146)
Structural organization of the DR subregion of the human major histocompatibility complex. (1985) (146)
Nomenclature for factors of the HLA system, 2000. (2001) (145)
Human major histocompatibility complex contains a minimum of 19 genes between the complement cluster and HLA-B. (1989) (145)
Tumor necrosis factor alpha is an autocrine growth factor for normal human B cells. (1994) (144)
VLA‐1: a T cell surface antigen which defines a novel late stage of human T cell activation (1985) (143)
Demonstration of structural polymorphism among HLA-DR light chains by two-dimensional gel electrophoresis (1980) (142)
Direct evidence of homology between human DC-1 antigen and murine I-A molecules (1982) (141)
The λδ T cell receptor and class lb MHC-related proteins: Enigmatic molecules of immune recognition (1989) (141)
Characterization and expression of the human alpha beta T cell receptor by using a framework monoclonal antibody. (1987) (140)
Mutually exclusive use of viral promoters in Epstein-Barr virus latently infected lymphocytes. (1989) (140)
Molecular cloning of Ly-1, a membrane glycoprotein of mouse T lymphocytes and a subset of B cells: molecular homology to its human counterpart Leu-1/T1 (CD5). (1987) (139)
Allele-specific peptide ligand motifs of HLA-C molecules. (1993) (139)
A gene pair from the human major histocompatibility complex encodes large proline-rich proteins with multiple repeated motifs and a single ubiquitin-like domain. (1990) (139)
Human HLA-G+ extravillous trophoblasts: Immune-activating cells that interact with decidual leukocytes (2015) (138)
Myosin IIA is required for cytolytic granule exocytosis in human NK cells (2007) (138)
Characterization of antigen recognized by the monoclonal antibody (4F2): different molecular forms on human T and B lymphoblastoid cell lines. (1982) (137)
Structure of HLA antigens: amino-acid and carbohydrate compositions and NH2-terminal sequences of four antigen preparations. (1976) (137)
Cysteines in the transmembrane region of major histocompatibility complex antigens are fatty acylated via thioester bonds. (1984) (136)
The very late antigen family of heterodimers is part of a superfamily of molecules involved in adhesion and embryogenesis. (1987) (135)
Papain-solubilized HL-A antigens from cultured human lymphocytes contain two peptide fragments. (1973) (135)
Constitutive endocytosis of HLA class I antigens requires a specific portion of the intracytoplasmic tail that shares structural features with other endocytosed molecules. (1989) (134)
Biochemical characterization of VLA-1 and VLA-2. Cell surface heterodimers on activated T cells. (1985) (133)
Specificity of OKT4+ cytotoxic T lymphocyte clones. (1982) (133)
CD28-stimulated ERK2 phosphorylation is required for polarization of the microtubule organizing center and granules in YTS NK cells (2006) (133)
Signaling at the inhibitory natural killer cell immune synapse regulates lipid raft polarization but not class I MHC clustering (2001) (132)
cDNA clone for the heavy chain of the human B cell alloantigen DC1: strong sequence homology to the HLA-DR heavy chain. (1982) (131)
Biosythesis of the peptidoglycan of bacterial cell walls. II. Phospholipid carriers in the reaction sequence. (1967) (130)
Carbohydrate moiety of HLA antigens. Antigenic properties and amino acid sequences around the site of glycosylation. (1977) (130)
Structure of the peptidoglycan of bacterial spores: occurrence of the lactam of muramic acid. (1969) (129)
Transactivation by CIITA, the type II bare lymphocyte syndrome-associated factor, requires participation of multiple regions of the TATA box binding protein. (1997) (129)
Gene organization of DC and DX subregions of the human major histocompatibility complex. (1985) (129)
The heavy chain of human histocompatibility antigen HLA-B7 contains an immunoglobulin-like region (1979) (128)
Monomeric Recombinant MD-2 Binds Toll-like Receptor 4 Tightly and Confers Lipopolysaccharide Responsiveness* (2002) (128)
Kinetics of interaction of HLA-C ligands with natural killer cell inhibitory receptors. (1998) (127)
Zinc regulates the function of two superantigens. (1992) (126)
Separate Functional Domains of Human MD-2 Mediate Toll-Like Receptor 4-Binding and Lipopolysaccharide Responsiveness 1 (2003) (125)
A membrane enzyme from Staphylococcus aureus which catalyzes transpeptidase, carboxypeptidase, and penicillinase activities. (1978) (124)
Identification of the nonamer peptide from influenza A matrix protein and the role of pockets of HLA‐A2 in its recognition by cytotoxic T lymphocytes (1992) (123)
The mechanism of action of penicillin. Penicillin acylates the active site of Bacillus stearothermophilus D-alanine carboxypeptidase. (1980) (123)
Structural (shape-maintaining) role of the cell surface glycoprotein of Halobacterium salinarium. (1976) (123)
Purification to homogeneity and properties of two D-alanine carboxypeptidases I From Escherichia coli. (1976) (121)
Purification and structural characterisation of human HLA-linked B-cell antigens (1977) (121)
Phosphorylation-dependent down-modulation of CD4 requires a specific structure within the cytoplasmic domain of CD4. (1991) (120)
Promiscuous binding of synthetic copolymer 1 to purified HLA-DR molecules (1997) (120)
STRUCTURE OF THE CELL WALL OF STAPHYLOCOCCUS AUREUS, STRAIN COPENHAGEN. II. SEPARATION AND STRUCTURE OF DISACCHARIDES. (1963) (118)
Human T-cell gamma chain genes: organization, diversity, and rearrangement. (1986) (118)
Class II-antigen-negative patient and mutant B-cell lines represent at least three, and probably four, distinct genetic defects defined by complementation analysis. (1991) (117)
Comparison of the P2 specificity pocket in three human histocompatibility antigens: HLA-A*6801, HLA-A*0201, and HLA-B*2705. (1993) (117)
Regulation of a transfected human class II major histocompatibility complex gene in human fibroblasts. (1986) (114)
Novel surface antigen expressed on dividing cells but absent from nondividing cells (1980) (113)
Transformation by Epstein-Barr virus requires DNA sequences in the region of BamHI fragments Y and H (1985) (113)
Heavy chain of HLA-A and HLA-B antigens is conformationally labile: a possible role for beta 2-microglobulin. (1979) (113)
Antigenic stimulation regulates the level of expression of interleukin 2 receptor on human T cells. (1984) (111)
Natural killer cell lines kill autologous beta2-microglobulin-deficient melanoma cells: implications for cancer immunotherapy. (1997) (111)
The HLA-G cycle provides for both NK tolerance and immunity at the maternal–fetal interface (2015) (111)
T cell apoptosis at the maternal–fetal interface in early human pregnancy, involvement of galectin-1 (2008) (111)
Multiple differences in gene expression in regulatory Vα24JαQ T cells from identical twins discordant for type I diabetes (2000) (111)
Biosynthesis of the Peptidoglycan of Bacterial Cell Walls III. THE ROLE OF SOLUBLE RIBONUCLEIC ACID AND OF LIPID INTERMEDIATES IN GLYCINE INCORPORATION IN STAPHYLOCOCCUS AUREUS (1967) (110)
Exclusive expression of Epstein-Barr virus nuclear antigen 1 in Burkitt lymphoma arises from a third promoter, distinct from the promoters used in latently infected lymphocytes. (1991) (110)
Thymidine diphosphate 4-keto-6-deoxy-d-glucose, an intermediate in thymidine diphosphate L-rhamnose synthesis in Escherichia coli strains. (1962) (109)
Mechanism of penicillin action: penicillin and substrate bind covalently to the same active site serine in two bacterial D-alanine carboxypeptidases. (1979) (109)
Amino acid residues that flank core peptide epitopes and the extracellular domains of CD4 modulate differential signaling through the T cell receptor (1994) (109)
Biosynthesis of the peptidoglycan of bacterial cell walls. XIV. Purification and properties of two D-alanine carboxypeptidases from Escherichia coli. (1968) (109)
Chemical structure of teichoic acid from Staphylococcus aureus, strain Copenhagen. (1962) (109)
Molecular cloning of a human histocompatibility antigen cDNA fragment. (1980) (108)
Signals for retention of transmembrane proteins in the endoplasmic reticulum studied with CD4 truncation mutants. (1991) (108)
Structure of the peptidoglycan from vegetative cell walls of Bacillus subtilis. (1971) (108)
JNK MAP kinase activation is required for MTOC and granule polarization in NKG2D-mediated NK cell cytotoxicity (2008) (107)
Biosynthesis of the peptidoglycan of bacterial cell walls. XII. Inhibition of cross-linking by penicillins and cephalosporins: studies in Staphylococcus aureus in vivo. (1968) (107)
Effect of mutations and variations of HLA-A2 on recognition of a virus peptide epitope by cytotoxic T lymphocytes. (1988) (106)
Structure of the Cell Wall of Staphylococcus aureus StrainCopenhagen. VI. The Soluble Glycopeptide and Its Sequential Degradatuib by Peptidases (1965) (106)
Formation of a WIP-, WASp-, actin-, and myosin IIA–containing multiprotein complex in activated NK cells and its alteration by KIR inhibitory signaling (2006) (106)
Phosphotyrosine-independent binding of a 62-kDa protein to the src homology 2 (SH2) domain of p56lck and its regulation by phosphorylation of Ser-59 in the lck unique N-terminal region. (1995) (106)
Structural features of the cytoplasmic region of CD4 required for internalization. (1990) (106)
Deficient natural killer cell cytotoxicity in patients with IKK-gamma/NEMO mutations. (2002) (105)
Multiple penicillin-binding components in Bacillus subtilis, Bacillus cereus, Staphylococcus aureus, and Escherichia coli. (1972) (104)
Complete amino acid sequence of a papain-solubilized human histocompatibility antigen, HLA-B7. 2. Sequence determination and search for homologies. (1979) (104)
CD1d-restricted T cells regulate dendritic cell function and antitumor immunity in a granulocyte–macrophage colony-stimulating factor-dependent fashion (2003) (103)
Molecular cloning of complementary DNAs encoding the heavy chain of the human 4F2 cell-surface antigen: a type II membrane glycoprotein involved in normal and neoplastic cell growth. (1987) (103)
Enhancement of Class II-Restricted T cell Responses by Costimulatory NK Receptors for Class I MHC Proteins (1996) (102)
Microbial uridine-5'-pyrophosphate N-acetylamino sugar compounds. I. Biology of the penicillin-induced accumulation. (1957) (102)
Mechanism of Action and Development of Resistance to a New Amidino Penicillin (1974) (102)
A novel cysteine-rich sequence-specific DNA-binding protein interacts with the conserved X-box motif of the human major histocompatibility complex class II genes via a repeated Cys-His domain and functions as a transcriptional repressor (1994) (101)
TGF‐β affects development and differentiation of human natural killer cell subsets (2010) (101)
The binding site of NK receptors on HLA-C molecules. (1997) (101)
Analysis of the transcript encoding the latent Epstein-Barr virus nuclear antigen I: a potentially polycistronic message generated by long-range splicing of several exons. (1985) (101)
Peptidoglycan transpeptidase and D-alanine carboxypeptidase: penicillin-sensitive enzymatic reactions. (1967) (100)
Expression of Recombinant HLA-DR2 Molecules (1996) (100)
Human X-box-binding protein 1 is required for the transcription of a subset of human class II major histocompatibility genes and forms a heterodimer with c-fos. (1991) (99)
Extensive junctional diversity of rearranged human T cell receptor delta genes. (1988) (98)
Calcineurin mediates human tumor necrosis factor alpha gene induction in stimulated T and B cells (1994) (98)
Studies of carcinogenesis by avian sarcoma viruses. II. Virus-induced increase in hyaluronic acid synthetase in chicken fibroblasts. (1966) (97)
Bacterial cell wall synthesis and structure in relation to the mechanism of action of penicillins and other antibacterial agents. (1965) (96)
Self-Specific Memory Regulatory T Cells Protect Embryos at Implantation in Mice (2013) (96)
Novel Species of tRNA (1971) (96)
Differential induction of IgE-mediated anaphylaxis after soluble vs. cell-bound tolerogenic peptide therapy of autoimmune encephalomyelitis. (2005) (96)
Self-peptides bound to the type I diabetes associated class II MHC molecules HLA-DQ1 and HLA-DQ8. (1994) (96)
The Translin Ring Specifically Recognizes DNA Ends at Recombination Hot Spots in the Human Genome* (1997) (96)
The mature activating natural killer cell immunologic synapse is formed in distinct stages (2003) (95)
Three Types of Functional Regulatory T Cells Control T Cell Responses at the Human Maternal-Fetal Interface. (2019) (95)
The killer's kiss: the many functions of NK cell immunological synapses. (2008) (95)
Phosphorylation of Ser-42 and Ser-59 in the N-terminal region of the tyrosine kinase p56lck. (1993) (94)
Detergent-soluble HLA antigens contain a hydrophilic region at the COOH-terminus and a penultimate hydrophobic region. (1976) (94)
Linkage disequilibrium between TAP2 variants and HLA class II alleles; no primary association between TAP2 variants and insulin‐dependent diabetes mellitus (1993) (94)
Cloning and sequence analysis of the human major histocompatibility complex gene DC-3 beta. (1984) (94)
cAMP inducibility of transcriptional repressor ICER in developing and mature human T lymphocytes. (1996) (94)
Comparison of amino acid sequences of two human histocompatibility antigens, HLA-A2 and HLA-B7: location of putative alloantigenic sites. (1979) (93)
Structure and polymorphism of the HLA class II SB light chain genes. (1984) (93)
Human NK cells: their ligands, receptors and functions (1997) (92)
Protein and Carbohydrate Composition of the Cell Envelope of Halobacterium salinarium (1974) (92)
Self and viral peptides can initiate lysis by autologous natural killer cells. (1997) (92)
Cloning and mapping of BamHi endonuclease fragments of DNA from the transforming B95-8 strain of Epstein-Barr virus. (1980) (91)
Genomic organization of the human T-cell antigen-receptor alpha/delta locus. (1988) (91)
Mixed signature of activation and dysfunction allows human decidual CD8+ T cells to provide both tolerance and immunity (2017) (90)
The quantitative histochemistry of brain. IV. Lactic, malic, and glutamic dehydrogenases. (1955) (90)
Five penicillin-binding components occur in Bacillus subtilis membranes. (1972) (90)
Genetic mapping of a human class II antigen beta-chain cDNA clone to the SB region of the HLA complex. (1983) (89)
p56lck association with CD4 is required for the interaction between CD4 and the TCR/CD3 complex and for optimal antigen stimulation. (1992) (88)
Uridine diphosphoglucose dehydrogenase of pea seedlings. (1957) (88)
Enzymatic polymerization of UDP-acetylmuramyl.L-ala.D-glu.L-lys.D-ala.D-ala and UDP-acetylglucosamine by a particulate enzyme from Staphylococcus aureus and its inhibition by antibiotics. (1964) (87)
Biosynthesis of the peptidoglycan of bacterial cell walls. XXI. Isolation of free C55-isoprenoid alcohol and of lipid intermediates in peptidoglycan synthesis from Staphylococcus aureus. (1970) (87)
Differentiation of human T lymphocytes. I. Acquisition of a novel human cell surface protein (p80) during normal intrathymic T cell maturation. (1983) (87)
CD43, the major sialoglycoprotein of human leukocytes, is proteolytically cleaved from the surface of stimulated lymphocytes and granulocytes. (1993) (87)
The amino acid sequence and gene organization of the heavy chain of the HLA-DR antigen: homology to immunoglobulins. (1982) (87)
Structure of the cell wall of Staphylococcus aureus, strain Copenhagen. VII. Mode of action of the bacteriolytic peptidase from Myxobacter and the isolation of intact cell wall polysaccharides. (1967) (86)
Natural killer activating receptors trigger interferon gamma secretion from T cells and natural killer cells. (1998) (85)
The Relation Between Water Intake and Food Intake in Normal Rats and in Rats with Hypothalamic Hyperphagia * (1947) (85)
Incorporation of glycine into the cell wall glycopeptide in Staphylococcus aureus: role of sRNA and lipid intermediates. (1965) (85)
Nomenclature for factors of the HLA system, 1991 (1992) (85)
Host-cell-determined methylation of specific Epstein-Barr virus promoters regulates the choice between distinct viral latency programs (1997) (85)
On the structure of the cell wall of staphylococcusaureus(Copenhagen) (1961) (84)
Decidual NK Cells Transfer Granulysin to Selectively Kill Bacteria in Trophoblasts (2020) (83)
OXAMYCIN, A COMPETITIVE ANTAGONIST OF THE INCORPORATION OF D-ALANINE INTO A URIDINE NUCLEOTIDE IN STAPHYLOCOCCUS AUREUS (1959) (83)
Constitutive activation of Epstein-Barr virus (EBV) nuclear antigen 1 gene transcription by IRF1 and IRF2 during restricted EBV latency (1997) (83)
Multiple receptors for HLA-G on human natural killer cells. (1997) (83)
Structure of crossreactive human histocompatibility antigens HLA-A28 and HLA-A2: possible implications for the generation of HLA polymorphism. (1982) (82)
An Epstein-Barr virus transcript from a latently infected, growth-transformed B-cell line encodes a highly repetitive polypeptide. (1986) (82)
Additional Antibiotic Inhibitors of Peptidoglycan Synthesis (1973) (82)
Purification and properties of penicillin-binding proteins 5 and 6 from Escherichia coli membranes. (1980) (82)
CD8+ Effector T Cells at the Fetal–Maternal Interface, Balancing Fetal Tolerance and Antiviral Immunity (2013) (82)
Functional three-domain single-chain T-cell receptors. (1994) (81)
Nomenclature for factors of the HLA system, 1991. The WHO Nomenclature Committee for factors of the HLA system. (1992) (81)
Human T-cell γ genes contain N segments and have marked junctional variability (1986) (81)
Identification of the Major Penicillin-Binding Proteins of Escherichia coli as d-Alanine Carboxypeptidase IA (1976) (80)
Involvement of caspase-cleaved and intact adaptor protein 1 complex in endosomal remodeling in maturing dendritic cells (2005) (80)
Molecular genetics of the human major histocompatibility complex. (1986) (79)
Minute quantities of a single immunodominant foreign epitope are presented as large nested sets by major histocompatibility complex class II molecules (1993) (79)
Analysis of HLA-DR antigens by using monoclonal antibodies: recognition of conformational differences in biosynthetic intermediates. (1981) (78)
Purification of papain-solubilized histocompatibility antigens from a cultured human lymphoblastoid line, RPMI 4265. (1975) (77)
Biosynthesis of the peptidoglycan of bacterial cell walls. XVI. The reversible fixation of radioactive penicillin G to the D-alanine carboxypeptidase of Bacillus subtilis. (1970) (77)
Virus-immune cytotoxic T cells recognize structural differences between serologically indistinguishable HLA-A2 molecules. (1980) (77)
Promoting tolerance to proteolipid protein-induced experimental autoimmune encephalomyelitis through targeting dendritic cells (2010) (77)
The HCMV membrane glycoprotein US10 selectively targets HLA-G for degradation (2010) (76)
Enzymatic Synthesis of the Peptide in Bacterial Uridine Nucleotides II. ENZYMATIC SYNTHESIS AND ADDITION OF d-ALANYL-d-ALANINE (1962) (76)
cDNA clones for the heavy chain of HLA-DR antigens obtained after immunopurification of polysomes by monoclonal antibody. (1982) (75)
Human T cell surface antigens bearing a structural relationship to HLA antigens. (1981) (75)
Simultaneous deletion of D-alanine carboxypeptidase IB-C and penicillin-binding component IV in a mutant of Escherichia coli K12. (1977) (74)
Nomenclature for Factors of the HLA System, 1990 (1991) (74)
Biosynthesis of the peptidoglycan of bacterial cell walls. XIX. Isoprenoid alcohol phosphokinase. (1970) (74)
Enzymatic Synthesis of the Peptide in Bacterial Uridine Nucleotides I. ENZYMATIC ADDITION OF l-ALANINE, d-GLUTAMIC ACID, AND l-LYSINE (1962) (74)
Complex transcription of the Epstein-Barr virus BamHI fragment H rightward open reading frame 1 (BHRF1) in latently and lytically infected B lymphocytes. (1988) (74)
Dissociation and exchange of the beta 2-microglobulin subunit of HLA-A and HLA-B antigens. (1979) (74)
Interferon gamma response region in the promoter of the human DPA gene. (1990) (74)
Characterization of a third form of the human T cell receptor gamma/delta (1988) (74)
Isolation and structural characterization of the human 4F2 heavy-chain gene, an inducible gene involved in T-lymphocyte activation (1988) (73)
Human and murine class I MHC antigens share conserved serine 335, the site of HLA phosphorylation in vivo. (1984) (73)
Human lymphocyte function associated antigen-1 (LFA-1): identification of multiple antigenic epitopes and their relationship to CTL-mediated cytotoxicity. (1983) (73)
Altered penicillin-binding components in penicillin-resistant mutants of Bacillus subtilis. (1976) (73)
Relation of detergent HLB number to solubilization and stabilization of D-alanine carboxypeptidase from Bacillus subtilis membranes. (1973) (73)
Sequence of active site peptides from the penicillin-sensitive D-alanine carboxypeptidase of Bacillus subtilis. Mechanism of penicillin action and sequence homology to beta-lactamases. (1980) (73)
Contrasting Effects of EWI Proteins, Integrins, and Protein Palmitoylation on Cell Surface CD9 Organization* (2006) (72)
Phosphorylation in vivo and in vitro of human histocompatibility antigens (HLA-A and HLA-B) in the carboxy-terminal intracellular domain. (1978) (72)
Biosynthesis of the peptidoglycan of bacterial cell walls. 18. Purification and properties of L-alanyl transfer ribonucleic acid-uridine diphosphate-N-acetylmuramyl-pentapeptide transferase from Lactobacillus viridescens. (1970) (72)
CD1d on Myeloid Dendritic Cells Stimulates Cytokine Secretion from and Cytolytic Activity of Vα24JαQ T Cells: A Feedback Mechanism for Immune Regulation1 (2000) (72)
Purification of HLA-linked B lymphocyte alloantigens in immunologically active form by preparative sodium dodecyl sulfate-gel electrophoresis and studies on their subunit association. (1977) (72)
Use of HLA loss mutants to analyse the structure of the human major histocompatibility complex (1982) (72)
Penicillin-sensitive enzymatic reactions in bacterial cell wall synthesis. (1968) (71)
Morphology of an Escherichia coli mutant with a temperature-dependent round cell shape (1978) (71)
Nucleotide sequence of the pbpA gene and characteristics of the deduced amino acid sequence of penicillin-binding protein 2 of Escherichia coli K12. (1986) (71)
STRUCTURE OF THE CELL WALL OF STAPHYLOCOCCUS AUREUS, STRAIN COPENHAGEN. IV. THE TEICHOIC ACID-GLYCOPEPTIDE COMPLEX. (1965) (71)
A critical role for conserved residues in the cleft of HLA-A2 in presentation of a nonapeptide to T cells. (1992) (71)
HLA-DR light chain has a polymorphic N-terminal region and a conserved immunoglobulin-like C-terminal region (1982) (70)
The two membrane proximal domains of CD4 interact with the T cell receptor (1996) (70)
Heterogeneity of TLR-induced responses in dendritic cells: from innate to adaptive immunity. (2004) (70)
Monitoring peripheral nerve degeneration in ALS by label-free stimulated Raman scattering imaging (2016) (70)
Mutational evidence for identity of penicillin-binding protein 5 in Escherichia coli with the major D-alanine carboxypeptidase IA activity (1979) (70)
Sphere-Rod Morphogenesis in Arthrobacter crystallopoietes I. Cell Wall Composition and Polysaccharides of the Peptidoglycan (1967) (69)
Disruption of the CD4-p56lck complex is required for rapid internalization of CD4. (1992) (69)
Nomenclature for Factors of the HLA System, 1996 (1997) (69)
Biosynthesis of the peptidoglycan of bacterial cell walls. VII. Incorporation of serine and glycine into interpeptide bridges in Staphylococcus epidermidis. (1968) (68)
A distant trophoblast-specific enhancer controls HLA-G expression at the maternal–fetal interface (2016) (68)
Isolation by covalent affinity chromatography of the penicillin-binding components from membranes of Bacillus subtilis. (1972) (67)
Uridine diphosphate acetylglucosamine phosphate and uridine diphosphate acetylgalactosamine sulfate. (1955) (67)
SB subregion of the human major histocompatibility complex: gene organization, allelic polymorphism and expression in transformed cells. (1985) (67)
MLL 5 protein forms intranuclear foci, and overexpression inhibits cell cycle progression. (2004) (67)
The Dual Role of HLA-C in Tolerance and Immunity at the Maternal-Fetal Interface (2019) (66)
AUTOLYSIS OF CELL WALLS OF BACILLUS SUBTILIS. MECHANISM AND POSSIBLE RELATIONSHIP TO COMPETENCE. (1964) (65)
A minimum of four human class II α-chain genes are encoded in the HLA region of chromosome 6 (1983) (65)
Double-negative (CD4-CD8-) lymphocytes bearing T-cell receptor alpha and beta chains in normal human skin. (1989) (65)
Binding of bacitracin to cells and protoplasts of Micrococcus lysodeikticus. (1974) (65)
Analysis of the oligosaccharides on the HLA-DR and DC1 B cell antigens. (1983) (65)
Induction of secondary cytotoxic T lymphocytes by purified HLA-A and HLA-B antigens reconstituted into phospholipid vesicles. (1978) (65)
Interaction between the human NK receptors and their ligands. (2000) (64)
Functional roles of the transcription factor Oct-2A and the high mobility group protein I/Y in HLA-DRA gene expression (1995) (64)
A Mechanism of Regulation of Food Intake * (1953) (64)
Identification of murine complement receptor type 2. (1989) (63)
Molecular analyses of the interactions between human NK receptors and their HLA ligands. (2000) (63)
Crystallization and X-ray diffraction studies on the histocompatibility antigens HLA-A2 and HLA-A28 from human cell membranes. (1985) (63)
Sequence of the COOH-terminal hydrophilic region of histocompatibility antigens HLA-A2 and HLA-B7. (1978) (63)
Binding motifs of copolymer 1 to multiple sclerosis- and rheumatoid arthritis-associated HLA-DR molecules. (1999) (62)
Biosynthesis of chitin in spores and growing cells of Blastocladiella emersonii. (1967) (62)
Organization of the transcriptional unit of a human class II histocompatibility antigen: HLA-DR heavy chain. (1983) (62)
Enzymatic sulfation of mucopolysaccharides in hen oviduct. II. Mechanism of the reaction studied with oligosaccharides and monosaccharides as acceptors. (1960) (62)
Translocation of TCR alpha chains into the lumen of the endoplasmic reticulum and their degradation. (1993) (62)
Dendritic cell and natural killer cell cross-talk: a pivotal role of CX3CL1 in NK cytoskeleton organization and activation. (2008) (61)
Impaired spontaneous endocytosis of HLA‐G (1997) (61)
Separation of three class II antigens from a homozygous human B cell line. (1983) (61)
Partial purification of detergent-soluble HL-A antigen and its cleavage by papain. (1974) (60)
Transcription of the tumor necrosis factor alpha gene is rapidly induced by anti-immunoglobulin and blocked by cyclosporin A and FK506 in human B cells. (1992) (60)
Delineation of immunologically and biochemically distinct HLA-A2 antigens. (1982) (60)
Sequence-specific interactions of nuclear factors with conserved sequences of human class II major histocompatibility complex genes. (1987) (60)
Characterization of the ZI domains in the Epstein-Barr virus BZLF1 gene promoter: role in phorbol ester induction (1996) (60)
Further structural studies of the heavy chain of HLA antigens and its similarity to immunoglobulins. (1977) (60)
Comparative structural analysis of HLA-A2 antigens distinguishable by cytotoxic T lymphocytes. II. Variant DK1: evidence for a discrete CTL recognition region. (1983) (59)
Active suppression of major histocompatibility complex class II gene expression during differentiation from B cells to plasma cells. (1988) (59)
NK-cell receptors and recognition of MHC class I molecules. (1996) (58)
WIP is essential for lytic granule polarization and NK cell cytotoxicity (2008) (58)
Uridine diphosphoacetylglucosamine pyrophosphorylase. (1959) (58)
Structure of the Cell Wall of Staphylococcus aureus, Strain Copenhagen. III. Further Studies of the Disaccharides* (1965) (58)
T cell subsets in normal human epidermis. (1996) (58)
Biosynthesis of the peptidoglycan of bacterial cell walls. XI. Formation of the isoglutamine amide group in the cell walls of Staphylococcus aureus. (1968) (57)
Generation of diversity of the beta chain of the human T-lymphocyte receptor for antigen. (1986) (57)
Monoclonal Antibodies Specific for the Empty Conformation of HLA-DR1 Reveal Aspects of the Conformational Change Associated with Peptide Binding* (2004) (57)
Mechanisms of enzymatic bacteriaolysis. Cell walls of bacteri are solubilized by action of either specific carbohydrases or specific peptidases. (1967) (56)
A pH-sensitive histidine residue as control element for ligand release from HLA-DR molecules (2002) (56)
The Epstein-Barr virus BamHI F promoter is an early lytic promoter: lack of correlation with EBNA 1 gene transcription in group 1 Burkitt's lymphoma cell lines (1995) (56)
Isolation of 4-o-β-N-acetylmuramyl-N-acetylglucosamine and 4-O-β-N,6-0-diacetylmuramyl-N-acetylglucosamine and the structure of the cell wall polysaccharide of Staphylococcusaureus (1966) (56)
Disruption of the SCL locus in T-lymphoid malignancies correlates with commitment to the T-cell receptor alpha beta lineage. (1992) (56)
Co-expression of HLA DR3 and DQ8 results in the development of spontaneous insulitis and loss of tolerance to GAD65 in transgenic mice. (2000) (56)
Differential effect of phosphonoacetic acid on the expression of Epstein-Barr viral antigens and virus production. (1976) (56)
Expression of KIR2DS1 by decidual natural killer cells increases their ability to control placental HCMV infection (2016) (55)
Functional analysis of a cytoplasmic domain-deleted mutant of the CD4 molecule. (1988) (55)
Regulation of food intake in normal rats and in rats with hypothalamic hyperphagia. (1953) (55)
Nomenclature for factors of the HLA system, 1991 (1992) (55)
Polymorphism and complexity of the human DC and murine I‐A alpha chain genes. (1983) (55)
Penicillins and cephalosporins are active site-directed acylating agents: evidence in support of the substrate analogue hypothesis. (1980) (55)
Comparison of the secondary structures of human class I and class II major histocompatibility complex antigens by Fourier transform infrared and circular dichroism spectroscopy. (1989) (55)
An essential function for β-arrestin 2 in the inhibitory signaling of natural killer cells (2008) (55)
Amino acid copolymer-specific IL-10-secreting regulatory T cells that ameliorate autoimmune diseases in mice (2008) (55)
Inhibition of antibody-dependent cellular cytotoxicity and immunoglobulin synthesis by an antiserum prepared against a human B- cell Ia-like molecule (1976) (54)
Cytotoxic potential of decidual NK cells and CD8+ T cells awakened by infections. (2017) (54)
Mapping of the mecillinam-resistant, round morphological mutants of Escherichia coli (1978) (54)
Biology of the human histocompatibility leukocyte antigen (HLA) system and a hypothesis regarding the generation of autoimmune diseases. (1986) (53)
Immune correlates of protection from HIV and AIDS - more answers but yet more questions. (1999) (53)
Partial primary structure of the alpha and beta chains of human tumor T-cell receptors. (1985) (53)
Isolation of HLA-DR1.(staphylococcal enterotoxin A)2 trimers in solution. (1995) (53)
Immunochemically purified DR antigens in liposomes stimulate xenogeneic cytolytic T cells in secondary in vitro cultures. (1986) (53)
Ligand Exchange of Major Histocompatibility Complex Class II Proteins Is Triggered by H-bond Donor Groups of Small Molecules* (2002) (53)
Structure of human T-cell receptors specific for an immunodominant myelin basic protein peptide: positioning of T-cell receptors on HLA-DR2/peptide complexes. (1995) (53)
Both chains of HLA-DR bind to the membrane with a penultimate hydrophobic region and the heavy chain is phosphorylated at its hydrophilic carboxyl terminus. (1979) (53)
Granulocyte-Macrophage Colony-Stimulating Factor Induces an Expression Program in Neonatal Microglia That Primes Them for Antigen Presentation1 (2002) (52)
IL-3 Induces B7.2 (CD86) Expression and Costimulatory Activity in Human Eosinophils (2001) (52)
Enhanced representation of HL-A antigens on human lymphocytes after mitogenesis induced by phytohemagglutinin or Epstein-Barr virus. (1975) (51)
Cloning and sequence analysis of complementary DNA encoding an aberrantly rearranged human T-cell gamma chain. (1986) (51)
HLA-DP2: self peptide sequences and binding properties. (1997) (51)
Isolation of the Lipid Intermediate in Peptidoglycan Biosynthesis from Escherichia coli (1972) (51)
Inactivation of D-alanine carboxypeptidase by penicillins and cephalosporins is not lethal in Bacillus subtilis. (1971) (51)
The gamma delta T cell receptor. (1988) (50)
Molecular characterization of serologic recognition sites in the human HLA-A2 molecule. (1988) (50)
Mononucleotide acid anhydrides and related compounds as intermediates in metabolic reactions. (1960) (50)
Modification of Ser59 in the unique N-terminal region of tyrosine kinase p56lck regulates specificity of its Src homology 2 domain. (1995) (50)
Selective release of some invariant chain-derived peptides from HLA-DR1 molecules at endosomal pH (1994) (50)
Utilization of a depsipeptide substrate for trapping acyl-enzyme intermediates of penicillin-sensitive D-alanine carboxypeptidases. (1978) (50)
Induction and Suppression of an Autoimmune Disease by Oligomerized T Cell Epitopes (2000) (50)
Human decidual NK cells from gravid uteri and NK cells from cycling endometrium are distinct NK cell subsets. (2010) (50)
Detergent solubilization, purification, and separation of specificities of HLA antigens from a cultured human lymphoblastoid line, RPMI 4265. (1977) (49)
Site-directed mutagenesis of class I HLA genes. Role of glycosylation in surface expression and functional recognition (1987) (49)
Biosynthesis of the peptidoglycan of bacterial cell walls. XX. Identification of phosphatidylglycerol and cardiolipin as cofactors for isoprenoid alcohol phosphokinase. (1970) (49)
Comparative structural analysis of HLA-A2 antigens distinguishable by cytotoxic T lymphocytes: variants M7 and DR1. (1982) (49)
Superactivation of an immune response triggered by oligomerized T cell epitopes. (1997) (49)
Description of monoclonal antibody defining an HLA allotypic determinant that includes specificities within the B5 cross-reacting group. (1982) (49)
Trafficking of spontaneously endocytosed MHC proteins. (1999) (49)
Biochemical Studies of the Smooth-Rough Mutation in Salmonella minnesota (1965) (48)
Gestation stage-dependent mechanisms of invariant natural killer T cell-mediated pregnancy loss. (2006) (48)
Enzymatic activities in cultured human lymphocytes that dephosphorylate dolichyl pyrophosphate and dolichyl phosphate. (1980) (48)
Comparison between two peptide epitopes presented to cytotoxic T lymphocytes by HLA-A2. Evidence for discrete locations within HLA-A2. (1989) (47)
Biosynthesis of the peptidoglycan of bacterial cell walls. XV. The binding of radioactive penicillin to the particulate enzyme preparation of Bacillus subtilis and its reversal with hydroxylamine or thiols. (1970) (47)
An isotype-specific trans-acting factor is defective in a mutant B cell line that expresses HLA-DQ, but not -DR or -DP (1991) (47)
Sphere-Rod Morphogenesis in Arthrobacter crystallopoietes II. Peptides of the Cell Wall Peptidoglycan (1967) (47)
PENICILLIN‐SENSITIVE ENZYMES AND PENICILLIN‐BINDING COMPONENTS IN BACTERIAL CELLS * (1974) (47)
Biosynthesis of the peptidoglycan of bacterial cell walls. X. Further study of the glycyl transfer ribonucleic acids active in peptidoglycan synthesis in Staphylococcus aureus. (1968) (47)
THYMIDINE DIPHOSPHATE 4-ACETAMIDO-4, 6-DIDEOXYHEXOSES. I. ENZYMATIC SYNTHESIS BY STRAINS OF ESCHERICHIA COLI. (1964) (47)
Transfer of sugars from nucleoside diphosphosugar compounds to endogenous and synthetic dolichyl phosphate in human lymphocytes. (1974) (47)
C 55 -isoprenoid alcohol phosphokinase: an extremely hydrophobic protein from the bacterial membrane. (1971) (47)
Relationship between cortex content and properties of Bacillus sphaericus spores (1976) (47)
The optical configuration of the alanine residues in a uridine nucleotide and in the cell wall of Staphylococcus aureus. (1959) (46)
CD1d and CD1d‐restricted iNKT‐cells play a pivotal role in contact hypersensitivity (2005) (46)
Nomenclature for factors of the HLA system, 2002. (2002) (46)
Caspases and nitric oxide broadly regulate dendritic cell maturation and surface expression of class II MHC proteins. (2004) (46)
Amelioration of proteolipid protein 139-151-induced encephalomyelitis in SJL mice by modified amino acid copolymers and their mechanisms. (2004) (46)
Novel synthetic amino acid copolymers that inhibit autoantigen-specific T cell responses and suppress experimental autoimmune encephalomyelitis. (2002) (46)
Degradation of penicillin G to phenylacetylglycine by D-alanine carboxypeptidase from Bacillus stearothermophilus. (1975) (46)
Nomenclature for factors of the HLA System, 1996. (1997) (46)
Studies of the high molecular weight penicillin-binding proteins of Bacillus subtilis. (1979) (46)
Transformation of human lymphocytes by Epstein-Barr virus is inhibited by phosphonoacetic acid (1976) (45)
Recognition of HLA-A2 and -B7 antigens by cloned cytotoxic T lymphocytes after gene transfer into human and monkey, but not mouse, cells. (1984) (45)
Enzymic transfer of pyruvate to uridine diphosphoacetylglucosamine. (1958) (44)
An update to HLA Nomenclature, 2010 (2010) (44)
Some properties of uridine diphosphoglucose dehydrogenase. (1956) (44)
A zinc finger protein that represses transcription of the human MHC class II gene, DPA. (1996) (43)
ENZYMATIC SYNTHESIS OF THE PEPTIDE IN BACTERIAL URIDINE NUCLEOTIDES. III. PURIFICATION AND PROPERTIES OF L-LYSIN-ADDING ENZYME. (1964) (43)
Nucleotide Accumulation Induced in Staphylococcus aureus by Glycine (1965) (43)
T3 glycoprotein is functional although structurally distinct on human T-cell receptor gamma T lymphocytes. (1987) (43)
Substituents on the alpha-carboxyl group of D-glutamic acid in the peptidoglycan of several bacterial cell walls. (1967) (43)
Heterogeneity of HL-A antigen preparations is due to variable sialic acid content. (1974) (43)
The role of zinc in the binding of killer cell Ig-like receptors to class I MHC proteins. (2001) (43)
Investigation of in vivo activated T cells in multiple sclerosis and inflammatory central nervous system diseases. (1985) (43)
Primary structure of papain-solubilized human histocompatibility antigen HLA-B27. (1985) (43)
Expression and crystallization of the complex of HLA-DR2 (DRA, DRB1*1501) and an immunodominant peptide of human myelin basic protein. (1998) (43)
Enzymic synthesis of guanosine and cytidine triphosphates: a note on the nucleotide specificity of the pyruvate phosphokinase reaction. (1955) (42)
Purification and properties of C 55 -isoprenylpyrophosphate phosphatase from Micrococcus lysodeikticus. (1972) (42)
Biosynthesis of bacterial cell walls. (1962) (42)
HLA-A2 and HLA-B7 antigens are phosphorylated in vitro by rous sarcoma virus kinase (pp60v-src) at a tyrosine residue encoded in a highly conserved exon of the intracellular domain. (1983) (42)
Abelson virus-transformed lymphocytes: Null cells that modulate H-2 (1977) (42)
Modified amino acid copolymers suppress myelin basic protein 85-99-induced encephalomyelitis in humanized mice through different effects on T cells. (2004) (42)
Enzymatic sulfation of mucopolysaccharides in hen oviduct. III. Mechanism of sulfation of chondrotin and chondrotin sulfate A. (1960) (41)
Expression of the CD80 and CD86 molecules enhances cytotoxicity by human natural killer cells. (2000) (41)
Species-restricted recognition of transfected HLA-A2 and HLA-B7 by human CTL clones. (1986) (41)
Isolation and Identification of Acetylgalactosamine Monosulfates (1960) (41)
Glycosylation of the surface glycoprotein of Halobacterium salinarium via a cyclic pathway of lipid‐linked intermediates (1978) (41)
Uniquely Conformed Peptide-Containing β2-Microglobulin- Free Heavy Chains of HLA-B2705 on the Cell Surface1 (2002) (41)
Accumulation of uridine and cytidine nucleotides in Staphylococcus aureus inhibited by gentian violet. (1959) (41)
HLA-DR antigens have polymorphic light chains and invariant heavy chains as assessed by lysine-containing tryptic peptide analysis. (1980) (41)
Isolation and characterization of cDNA clones corresponding to transcripts from the BamHI H and F regions of the Epstein-Barr virus genome (1987) (41)
Biosynthesis of the peptidoglycan of bacterial cell walls. IV. Incorporation of glycine in Micrococcus lysodeikticus. (1967) (40)
Molecular Interaction and Enzymatic Activity of Macrophage Migration Inhibitory Factor with Immunorelevant Peptides* (2003) (40)
Reconstitution of purified detergent-soluble HLA-A and HLA-B antigens into phospholipid vesicles. (1978) (40)
Dual parameter flow cytometric analysis of DNA content, activation antigen expression, and T cell subset proliferation in the human mixed lymphocyte reaction. (1984) (40)
Biosynthesis of the peptidoglycan of bacterial cell walls. XVII. Biosynthesis of peptidoglycan and of interpeptide bridges in Lactobacillus viridescens. (1970) (40)
Structural analysis of an HLA-B7 antigen variant detected by cytotoxic T lymphocytes. (1984) (40)
Transcription of a subset of human class II major histocompatibility complex genes is regulated by a nucleoprotein complex that contains c-fos or an antigenically related protein. (1991) (40)
EM49: A NEW POLYPEPTIDE ANTIBIOTIC ACTIVE AGAINST CELL MEMBRANES (1974) (40)
Human fetal liver gamma/delta T cells predominantly use unusual rearrangements of the T cell receptor delta and gamma loci expressed on both CD4+CD8- and CD4-CD8- gamma/delta T cells (1993) (40)
D-alanine carboxypeptidase from Bacillus subtilis membranes. I. Purification and characterization. (1973) (40)
PENICILLIN-BINDI NG PROTEINS AND THE MECHANISM OF ACTION OF P-LACTAM ANTIBIOTICS 1 (1983) (40)
A SPECIFIC MICRODETERMINATION OF GLUCOSAMINE AND THE ANALYSIS OF OTHER HEXOSAMINES IN THE PRESENCE OF GLUCOSAMINE. (1964) (40)
Structure of the cell wall of Corynebacterium diphtheriae. I. Mechanism of hydrolysis by the L-3 enzyme and the structure of the peptide. (1968) (39)
Nucleoside monophosphate kinases. I. Transphosphorylation between adenosine triphosphate and nucleoside monophosphates. (1959) (39)
Human T-cell receptor (TCR) α/β+ CD4-CD8- T cells express oligoclonal TCRs, share junctional motifs across TCR Vβ-gene families, and phenotypically resemble memory T cells (1993) (39)
An Evaluation of the Significance of Amino Acid Sequence Homologies in Human Histocompatibility Antigens (HLA‐A and HLA‐B) with Immunoglobulins and Other Proteins, Using Relatively Short Sequences (1980) (39)
Formation of lipid-linked sugar compounds in Halobacterium salinarium. Presumed intermediates in glycoprotein synthesis. (1976) (39)
Alanine Racemase from Staphylococcus aureus: Conformation of Its Substrates and Its Inhibitor, D-Cycloserine (1966) (39)
How penicillin kills bacteria: progress and problems (1971) (38)
Activation of D-aspartic acid for incorporation into peptidoglycan. (1972) (38)
CHEMICAL BASIS FOR AN IMMUNOLOGICAL SPECIFICITY OF A STRAIN OF STAPHYLOCOCCUS AUREUS (1963) (38)
Enzymic removal and re-expression of a histocompatibility antigen, HL-A 2, at the surface of human peripheral lymphocytes ( 31 Cr-labeled cells-papain-puromycin-actinomycin D). (1972) (38)
Binding of soluble natural ligands to a soluble human T-cell receptor fragment produced in Escherichia coli. (1994) (38)
NOMENCLATURE FOR FACTORS OF THE HLA SYSTEM, 1995 (1995) (38)
Uridine and guanosine nucleotides of hen oviduct. (1962) (38)
Two distinct genetic loci regulating class II gene expression are defective in human mutant and patient cell lines. (1988) (38)
Enzymatic synthesis of cytidine diphosphate 3,6-dideoxyhexoses. 8. Mechanistic roles of enzyme E-1 and pyridoxamine 5'-phosphate in the formation of cytidine diphosphate-4-keto-3,6-dideoxy-D-glucose from cytidine diphosphate-4-keto-6-deoxy-D-glucose. (1974) (38)
VAMP4‐ and VAMP7‐expressing vesicles are both required for cytotoxic granule exocytosis in NK cells (2011) (38)
NLRP2 is a suppressor of NF-B signaling and HLA-C expression in human trophoblasts (2017) (37)
Peptide 15-mers of defined sequence that substitute for random amino acid copolymers in amelioration of experimental autoimmune encephalomyelitis. (2005) (37)
Alloreactivity studied with mutants of HLA-A2. (1989) (37)
Evidence for a shared HLA-A intralocus determinant defined by monoclonal antibody 131 (1985) (37)
Multiple differences in gene expression in regulatory Valpha 24Jalpha Q T cells from identical twins discordant for type I diabetes. (2000) (37)
Primary structure of papain-solubilized human histocompatibility antigen HLA-B40 (-Bw60). An outline of alloantigenic determinants. (1983) (37)
Conformational variants of class II MHC/peptide complexes induced by N- and C-terminal extensions of minimal peptide epitopes. (1999) (36)
Synthetic amino acid copolymers that bind to HLA-DR proteins and inhibit type II collagen-reactive T cell clones. (1998) (36)
Partial purification and properties of the Epstein-Barr virus-associated nuclear antigen. (1978) (36)
ENZYMATIC SYNTHESIS OF THE PEPTIDE IN BACTERIAL URIDINE NUCLEOTIDES. IV. PURIFICATION AND PROPERTIES OF D-GLUTAMIC ACID-ADDING ENZYME. (1964) (36)
Assembly and dissociation of human leukocyte antigen (HLA)-A2 studied by real-time fluorescence resonance energy transfer. (2000) (36)
Enzymatic synthesis and immunochemistry of alpha- and beta-N-acetylglucosaminylribitol linkages in teichoic acids from several strains of Staphylococcus aureus. (1966) (36)
The Transmembrane Sequence of Human Histocompatibility Leukocyte Antigen (HLA)-C as a Determinant in Inhibition of a Subset of Natural Killer Cells (1999) (36)
Genetic and biochemical characterization of a human surface determinant on somatic cell hybrids: The 4F2 antigen (1982) (36)
Conformational Variation of Surface Class II MHC Proteins during Myeloid Dendritic Cell Differentiation Accompanies Structural Changes in Lysosomal MIIC1 (2005) (36)
Purification of HLA-A2 antigen, fluorescent labeling of its intracellular region, and demonstration of an interaction between fluorescently labeled HLA-A2 antigen and lymphoblastoid cell cytoskeleton proteins in vitro. (1981) (36)
Nomenclature for Factors of the HLA System, 1998 (1999) (35)
Amino acid sequences in the alpha 1 domain and not glycosylation are important in HLA-A2/beta 2-microglobulin association and cell surface expression (1987) (35)
ON THE LINKAGE BETWEEN TEICHOIC ACID AND THE GLYCOPEPTIDE IN THE CELL WALL OF STAPHYLOCOCCUS AUREUS. (1963) (35)
HLA-D associated alloantisera react with molecules similar to Ia antigens. (1977) (35)
B-cell-specific enhancer activity of conserved upstream elements of the class II major histocompatibility complex DQB gene. (1988) (35)
THYMIDINE DIPHOSPHATE 4-ACETAMIDO-4,6-DIDEOXYHEXOSES. II. PURIFICATION AND PROPERTIES OF THYMIDINE DIPHOSPHATE D-GLUCOSE OXIDOREDUCTASE. (1965) (34)
Structure, Function, and Biosynthesis of the Major Human Histocompatibility Antigens (HLA‐A and HLA‐B) (1980) (34)
Biosynthesis of the peptidoglycan of bacterial cell walls. 8. Specificity in the utilization of L-alanyl transfer ribonucleic acid for interpeptide bridge synthesis in Arthrobacter crystallopoietes. (1968) (34)
Separation of specific mucopolysaccharide sulfotransferases (1961) (34)
Molecular analysis of an HLA-A2 functional variant CLA defined by cytolytic T lymphocytes. (1986) (34)
Isotypic and allotypic variation of human class II histocompatibility antigen alpha-chain genes. (1984) (34)
The B95-8 isolate of Epstein-Barr virus arose from an isolate with a standard genome (1982) (34)
Epstein-Barr virus in B lymphocytes: viral gene expression and function in latency. (1992) (34)
Gene mapping and somatic cell hybrid analysis of the role of human lymphocyte function-associated antigen-3 (LFA-3) in CTL-target cell interactions. (1986) (34)
Positioning of a peptide in the cleft of HLA-A2 by complementing amino acid changes. (1991) (34)
Molecular organization of the DQ subregion (DO-DX-DV-DQ) of the human MHC and its evolutionary implications. (1988) (34)
Purification and characterization of the thermophilic D-alanine carboxypeptidase from membranes of Bacillus stearothermophilus. (1974) (34)
The Immunoglobulin‐Like Structure of Human Histocompatibility Antigens (1974) (34)
Site-directed mutants of a soluble form of penicillin-binding protein 5 from Escherichia coli and their catalytic properties. (1988) (33)
A 55,000 Mr surface antigen on activated human T lymphocytes defined by a monoclonal antibody. (1983) (33)
Biosynthesis of the peptidoglycan of bacterial cell walls. VI. Incorporation of L-threonine into interpeptide bridges in Micrococcus roseus. (1968) (33)
Activation of C55-isoprenoid alcohol phosphokinase from Staphylococcus aureus. I. Activation by phospholipids and fatty acids. (1976) (33)
Synthesis of 4-Amino-4,6-dideoxy-D-galactose and Identification with the 4-Amino-4,6-dideoxyhexose from Escherichia coli Strain Y-10 (1964) (33)
Possible Detection of HLA‐DR Alloantigenic Specificities in Man with Unabsorbed Rabbit Antisera (1978) (33)
Isolation of thymidine diphosphosugar compounds from Escherichia coli. (1959) (33)
Staphylolytic Enzyme from Chalaropsis: Mechanism of Action (1964) (33)
Cell adhesion mediated by CD4 and MHC class II proteins requires active cellular processes. (1993) (32)
Structure and expression of HLA-DQα and -DXα genes: interallelic alternate splicing of the HLA-DQα gene and functional splicing of the HLA-DXα gene using a retroviral vector (2004) (32)
Enzymatic Dephosphorylation of C55-Isoprenylphosphate (1972) (32)
Nucleoside monophosphate kinases. II. Transphosphorylation betweeen adenosine monophosphate and nucleoside triphosphates. (1959) (31)
Accumulation of a uridine nucleotide in Staphylococcus aureus as the consequence of lysine deprivation. (1959) (31)
16 – Structure of Bacterial Cell Walls: The Lysozyme Substrate* (1974) (31)
Molecular characterization of MT3 antigens by two-dimensional gel electrophoresis, NH2-terminal amino acid sequence analysis, and southern blot analysis. (1985) (31)
Human histocompatibility proteins (2002) (31)
Recombination hotspot associated factors specifically recognize novel target sequences at the site of interchromosomal rearrangements in T-ALL patients with t(8;14)(q24;q11) and t(1;14)(p32;q11). (1994) (31)
Incorporation of inorganic sulfate-S35 into sulfated mucopolysaccharides of cornea in vitro. (1957) (30)
Orientation of loci within the human major histocompatibility complex by chromosomal in situ hybridization. (1984) (30)
Biochemical Effects of Novobiocin on Staphylococcus aureus (1965) (30)
Monoclonal antibodies reacting with immunogenic mycoplasma proteins present in human hematopoietic cell lines. (1982) (30)
Development and characterization of allospecific long-term human cytolytic T-cell lines. (1980) (30)
Complete amino acid sequence of a papain-solubilized human histocompatibility antigen HLA-B7. 1. Isolation and amino acid composition of fragments and of tryptic and chymotryptic peptides. (1979) (30)
Human Term Pregnancy Decidual NK Cells Generate Distinct Cytotoxic Responses (2020) (30)
Enzymatic synthesis and immunochemistry of N-acetylglucosaminylribitol linkages in the teichoic acids of Staphylococcus aureus stains. (1962) (29)
Activation of C55-isoprenoid alcohol phosphokinase from Staphylococcus aureus. III. Activation by detergents. (1976) (29)
IL-7 induces proliferation of CD3-/low CD4- CD8- human thymocyte precursors by an IL-2 independent pathway. (1992) (29)
The extracellular region of light chains from human and murine MHC class II antigens consists of two domains. (1983) (29)
Complex lipid requirements for detergent-solubilized phosphoacetylmuramyl-pentapeptide translocase from Micrococcus luteus. (1972) (29)
Dysfunction of dendritic cells in aged C57BL/6 mice leads to failure of natural killer cell activation and of tumor eradication (2014) (29)
Enzymatic synthesis of the peptide in bacterial uridine nucleotides. VII. Comparative biochemistry. (1973) (28)
Ristocetins, inhibitors of cell wall synthesis in Staphylococcus aureus. (1963) (28)
Expression of HLA-DR antigen in human class II mutant B-cell lines by double infection with retrovirus vectors (1987) (28)
Identification of shared antigenic determinants of the putative human T lymphocyte antigen receptor (1984) (28)
Penicillin-sensitive transpeptidation during peptidoglycan biosynthesis in cell-free preparations from Bacillus megaterium. II. Effect of penicillins and cephalosporins on bacterial growth and in vitro transpeptidation. (1972) (28)
Localization of the sites of iodination of human beta 2-microglobulin: quaternary structure implications for histocompatibility antigens. (1983) (28)
Nuclear proteins binding to a novel target sequence within the recombination hotspot regions of Bcl-2 and the immunoglobulin DH gene family. (1994) (28)
Viral and cellular DNA synthesis in nuclei from human lymphocytes transformed by Epstein-Barr virus. (1975) (28)
NOD background genes influence T cell responses to GAD 65 in HLA-DQ8 transgenic mice. (1999) (28)
Binding of soluble 125I-human C3b, the third component of complement, to specific receptors in human cultured B lymphoblastoids cells: characterization of a low affinity interaction. (1980) (28)
Enzymic synthesis of sulfated mucopolysaccharides in hen oviduct. (1959) (28)
Enzymatic synthesis of cytidine diphosphate 3,6-dideoxyhexoses. 3. Cytidine diphosphate D-glucose oxidoreductase. (1966) (28)
Transcriptome analysis reveals similarities between human blood CD3− CD56bright cells and mouse CD127+ innate lymphoid cells (2017) (28)
Polyribitol phosphate synthetase of Staphylococcus aureus. (1966) (28)
Chemical and immunochemical structure of teichoic acid from staphylococcusaureus(Copenhagen) (1961) (28)
Cyclosporin A and FK506 block induction of the Epstein-Barr virus lytic cycle by anti-immunoglobulin. (1995) (28)
Penicillin-sensitive transpeptidation during peptidoglycan biosynthesis in cell-free preparations from Bacillus megaterium. I. Incorporation of free diaminopimelic acid into peptidoglycan. (1972) (27)
Submit and disulfide structure of monomeric and dimeric forms of detergent-soluble HLA antigens. (1977) (27)
Specificity of a Bacteriolytic Enzyme from Pseudomonas aeruginosa (1969) (27)
The human HLA specific monoclonal antibody W6/32 recognizes a discontinuous epitope within the α2 domain of murine H-2Db (2004) (27)
Recognition of HLA-A2 mutant and variant target cells by an HLA-A2 allospecific human cytotoxic T lymphocyte line. (1983) (27)
Structure of the cell wall of Micrococcus lysodeikticus. II. Study of the structure of the peptides produced after lysis with the Myxobacterium enzyme. (1967) (27)
Polymorphism in the tumor necrosis factor gene: Association with HLA-B and DR haplotypes (1988) (27)
Isolation of Polyisoprenyl Alcohols from Streptococcus faecalis (1972) (27)
Biosynthesis of the peptidoglycan of bacterial cell walls. IX. Purification and properties of glycyl transfer ribonucleic acid synthetase from Staphylococcus aureus. (1968) (27)
Suppression of in vitro Epstein-Barr virus infection: a new role for adult human T-lymphocytes. (1978) (26)
Enzymatic synthesis of cytidine diphosphate 3,6-dideoxyhexoses. 8. Studies of the properties of E3 and its role in the formation of cytidine diphosphate-4-keto-3,6-dideoxyglucose. (1974) (26)
Cleavage of a COOH-terminal hydrophobic region from D-alanine carboxypeptidase, a penicillin-sensitive bacterial membrane enzyme. Characterization of active, water-soluble fragments. (1979) (26)
Partial purification and characterization of an aspartate racemase from Streptococcus faecalis. (1972) (26)
Involvement of a tissue-specific autoantibody in skin disorders of murine systemic lupus erythematosus and autoinflammatory diseases. (2006) (26)
HLA-DR antigens of autologous melanoma and B lymphoblastoid cell lines: differences in glycosylation but not protein structure. (1984) (26)
HLA antigen structural gene mutants selected with an allospecific monoclonal antibody. (1982) (26)
Chemical and immunological characterization of HL-A linked B-lymphocyte alloantigens. (1977) (26)
Structural analysis of HLA-A2 antigen from immunoselected mutant 8.6.1: further definition of an HLA-A2-specific serological determinant. (1983) (26)
Linear, uncross-linked peptidoglycan secreted by penicillin-treated Bacillus subtilis. Isolation and characterization as a substrate for penicillin-sensitive D-alanine carboxypeptidases. (1980) (26)
Enzymatic synthesis of cytidine diphosphate 3,6-dideoxyhexoses. I. Over-all reactions. (1966) (26)
Enzymatic synthesis of cytidine diphosphate 3,6-dideoxyhexoses. VI. Purification to homogeneity and some properties of cytidine diphosphate-D-glucose oxidoreductase, enzyme E 1 and enzyme E 3 . (1972) (26)
ENZYMATIC SYNTHESIS OF N-ACETYLGLUCOSAMINYLRIBITOL LINKAGES IN TEICHOIC ACID FROM STAPHYLOCOCCUS AUREUS, STRAIN COPENHAGEN. (1963) (26)
β-Lactam Antibiotics: Biochemical Modes of Action (1982) (26)
Primary structure of the COOH-terminal membranous segment of a penicillin-sensitive enzyme purified from two Bacilli. (1981) (26)
Molecular involvement of the pvt-1 locus in a gamma/delta T-cell leukemia bearing a variant t(8;14)(q24;q11) translocation (1992) (26)
Bacterial cell walls, innate immunity and immunoadjuvants (2007) (26)
Amidation and cross-linking of the enzymatically synthesized peptidoglycan of Bacillus stearothermophilus. (1974) (26)
CD1d on myeloid dendritic cells stimulates cytokine secretion from and cytolytic activity of V alpha 24J alpha Q T cells: a feedback mechanism for immune regulation. (2000) (26)
Generation of long-term human cytolytic cell lines with persistent natural killer activity. (1982) (25)
Inhibition of sterol biosynthesis by bacitracin. (1972) (25)
Induction of secondary cytotoxic T lymphocytes by liposomes containing HLA-DR antigens (1980) (25)
Animal Antimicrobial Peptides: Ancient Players in Innate Immunity (2009) (25)
Human leucocyte antigen-G and its recognition by natural killer cells. (1999) (25)
Histocompatibility antigens : structure and function (1982) (25)
Rearrangement and expression of T-cell antigen receptor genes in human T-lymphocyte tumor lines and normal human T-cell clones: evidence for allelic exclusion of Ti beta gene expression and preferential use of a J beta 2 gene segment (1986) (25)
A homozygous human cell line contains three subsets of HLA-DR-like antigens distinguishable by amino acid sequencing. (1982) (25)
Effects of penicillin on the biosynthesis of the cell walls of Escherichia coli and Staphylococcus aureus. (1961) (25)
Interleukin‐12 and interleukin‐2‐induced invariant natural killer T‐cell cytokine secretion and perforin expression independent of T‐cell receptor activation (2003) (25)
Penicillin-Resistant Temperature-Sensitive Mutants of Escherichia coli Which Synthesize Hypo- or Hyper-Cross-Linked Peptidoglycan (1974) (25)
Human T cell proteins recognized by rabbit heteroantisera and monoclonal antibodies. (1981) (25)
Isolation and utilization of phospholipid intermediates in cell wall glycopeptide synthesis. (1965) (25)
Modulation of HLA class II antigen expression by transfection of sense and antisense DR alpha cDNA (1989) (24)
Isolation of the penicillin-binding peptide from D-alanine carboxypeptidase of Bacillus subtilis. (1977) (24)
Gamma-interferon induction of HLA class II mRNAs in dermal fibroblasts studied by RNAse protection analysis. (1990) (24)
Binding of (14C)penicillin G to the membrane-bound and the purified D-alanine carboxypeptidases from Bacillus stearothermophilus and Bacillus subtilis and its release. (1974) (24)
Bacitracin induces sphere formation in Halobacterium species which lack a wall peptidoglycan. (1975) (24)
Expression of complement proteins C2 and factor B in transfected L cells. (1985) (24)
Three types of HLA-G+ extravillous trophoblasts that have distinct immune regulatory properties (2020) (24)
Synthesis of peptidoglycan by high molecular weight penicillin-binding proteins of Bacillus subtilis and Bacillus stearothermophilus. (1984) (23)
Epstein-Barr virus transformation. (1987) (23)
[143A] Determination of UDPG and UTP by means of UDPG dehydrogenase (1957) (23)
HLA-A2 antigen phosphorylation in vitro by cyclic AMP-dependent protein kinase. Sites of phosphorylation and segmentation in class i major histocompatibility complex gene structure. (1984) (23)
Heterophile antibodies segregate in families and are associated with protection from type 1 diabetes. (1999) (23)
D-alanine carboxypeptidase from Bacillus subtilis membranes. II. Interaction with penicillins and cephalosporins. (1973) (23)
Vaccination, prevention, and treatment of experimental autoimmune neuritis (EAN) by an oligomerized T cell epitope (2001) (23)
Helix-loop-helix (E2-5, HEB, TAL1 and Id1) protein interaction with the TCRalphadelta enhancers. (1998) (23)
Antigen‐specific elimination of T cells induced by oligomerized hemagglutinin (HA) 306–318 (2000) (23)
Genetic and biochemical characterization of human lymphocyte cell surface antigens. The A-1A5 and A-3A4 determinants (1984) (23)
Binding of random copolymers of three amino acids to class II MHC molecules. (1999) (22)
Activation of C55-isoprenoid alcohol phosphokinase from Staphylococcus aureus. II. Biophysical studies. (1976) (22)
Clonal T lymphocyte recognition of the fine structure of the HLA-A2 molecule. (1985) (22)
Noncanonical Vα24JαQ T cells with conservative α chain CDR3 region amino acid substitutions are restricted by CD1d (1999) (22)
HLA-A2 mutants immunoselected in vitro. Definition of residues contributing to an HLA-A2-specific serological determinant (1983) (22)
Appearance of Muramic Lactam During Cortex Synthesis in Sporulating Cultures of Bacillus cereus and Bacillus megaterium (1972) (22)
An allosteric mechanism controls antigen presentation by the H-2K(b) complex. (1999) (22)
Enzymatic Synthesis of Cytidine Diphosphate 3,6-Dideoxyhexoses IV. PARTIAL RESOLUTION OF THE ENZYMES REQUIRED FOR REDUCTION OF CYTIDINE DIPHOSPHATE 4-KETO-6-DEOXY-d-GLUCOSE AND ISOLATION OF A NEW INTERMEDIATE (1967) (22)
Thymidine diphosphate 4-acetamido-2,6-dideoxyhexoses. 3. Purification and properties of thymidine diphosphate 4-keto-6-deoxy-D-glucose transaminase from Escherichia coli strain B. (1966) (22)
Crystallization of HLA-DR antigens. (1991) (22)
Identification and mapping of polypeptides encoded by the P3HR-1 strain of Epstein-Barr virus. (1984) (22)
The gamma delta T cell receptor and class Ib MHC-related proteins: enigmatic molecules of immune recognition. (1989) (22)
Differential responses of invariant V alpha 24J alpha Q T cells and MHC class II-restricted CD4+ T cells to dexamethasone. (1999) (22)
Exuberant restriction fragment length polymorphism associated with the DQ alpha-chain gene and the DX alpha-chain gene. (1985) (21)
Maturation or differentiation of human thymocyte precursors in vitro? (1990) (21)
Sequence analysis of the human major histocompatibility gene SX alpha (1985) (21)
Structure of the cell wall of Staphylococcus aureus. 8. Structure and chemical synthesis of the basic peptides released by the Myxobacterium enzyme. (1967) (21)
Expression and function of a CD 5 cDNA in human and murine T cells (1988) (21)
Subunit interactions of class I histocompatibility antigens. (1985) (21)
Penicillin-binding proteins in Bacillus subtilis mutants (1982) (21)
Delineation of a previously unrecognized cis-acting element required for HLA class II gene expression. (1991) (21)
A uridine diphosphoacetylmuramyl hexapeptide from penicillin-treated Streptococcus faecalis. (1962) (21)
Direct binding of the Mtv7 superantigen (Mls-1) to soluble MHC class II molecules. (1995) (20)
Synthetic peptides that inhibit binding of the myelin basic protein 85-99 epitope to multiple sclerosis-associated HLA-DR2 molecules and MBP-specific T-cell responses. (2001) (20)
Effects of sulfhydryl reagents on the binding and release of penicillin G by D-alanine carboxypeptidase IA of Escherichia coli. (1978) (20)
An unusually high-titer human anti-Epstein Barr virus (EBV) serum and its use in the study of EBV-specific proteins synthesized in vitro and in vivo. (1983) (20)
The dichotomy of peptide presentation by class I and class II MHC proteins. (1993) (20)
TAL1 expression does not occur in the majority of T‐ALL blasts (1998) (20)
Enzymatic utilization of P1-di-N-acetylchitobiosyl P2-dolichyl pyrophosphate and its chemical synthesis. (1974) (20)
Recognition of interspecies hybrid class I histocompatibility antigens by antigen-specific cytolytic T lymphocytes. (1985) (20)
Identification of the active site in penicillin-binding protein 3 of Escherichia coli (1985) (20)
NUCLEOTIDE INTERMEDIATES IN THE BIOSYNTHESIS OF HETEROPOLYMERIC POLYSACCHARIDES. (1964) (20)
Assembly and peptide binding of major histocompatibility complex class II heterodimers in an in vitro translation system. (1994) (20)
Secondary structure relations between beta-lactamases and penicillin-sensitive D-alanine-carboxypeptidases. (2009) (19)
Structure of HL-A A and B antigens isolated from cultured human lymphocytes. (1977) (19)
A factor that regulates the class II major histocompatibility complex gene DPA is a member of a subfamily of zinc finger proteins that includes a Drosophila developmental control protein (1994) (19)
Reversible inhibition by phosphonoacetic acid of human B lymphocyte transformation by Epstein-Barr virus. (1978) (19)
Papain-solubilized HL-A antigens. Chromatographic and electrophoretic studies of the two subunits from different specificities. (1974) (19)
Copolymer effects on microglia and T cells in the central nervous system of humanized mice (2005) (19)
Characterization of a cDNA clone corresponding to a transcript from the Epstein-Barr virus BamHI M fragment: evidence for overlapping mRNAs (1987) (19)
Analysis of the sheep MHC using HLA class I, II, and C4 cDNA probes (2004) (19)
Hydroxylaminolysis of penicillin binding componenets is enzymatically catalyzed. (1977) (19)
Structure of the cell wall of Staphylococcus aureaus. IX. Mechanism of hydrolysis by the L11 enzyme. (1968) (19)
Inhibition of proliferative and plaque-forming cell responses by human bone-marrow-derived lymphocytes from peripheral blood by antisera to the p23, 30 antigen. (1977) (19)
Purification and properties of penicillin-binding proteins 5 and 6 from the dacA mutant strain of Escherichia coli (JE 11191). (1984) (19)
Sequence of human β2-microglobulin: A correction (1982) (18)
Biosynthesis of the peptidoglycan of bacterial cell walls. V. Separation of protein and lipid components of the particulate enzyme from Micrococcus lysodeikticus and purification of the endogenous lipid acceptors. (1967) (18)
Structure of the Cell Wall of Staphylococcus aureus StrainCopenhagen. V. Isolation of Peptidases Active on the Peptide Moiety of the Cell Walls of Some Gram-Positive Bacteria (1965) (18)
Transglutaminase modifies the carboxy-terminal intracellular region of HLA-A and -B antigens (1981) (18)
A monoclonal antibody that recognizes the α chain of HLA-DR antigens (1986) (18)
Thymidine diphosphate N-acetylamino sugar compounds from Escherichia coli strains. (1962) (18)
Specificity of mouse cytotoxic T lymphocytes stimulated with either HLA-A and -B or HLA-DR antigens reconstituted into phospholipid vesicles. (1980) (18)
Synthetic peptides that inhibit binding of the collagen type II 261-273 epitope to rheumatoid arthritis-associated HLA-DR1 and -DR4 molecules and collagen-specific T-cell responses. (2000) (18)
Penicillin is an active-site inhibitor for four genera of bacteria (1982) (18)
Characterization of a B lymphoblastoid cell line mutant that secretes HLA-A2. (1984) (18)
Cephalosporin-sensitive penicillin-binding proteins of Staphylococcus aureus and Bacillus subtilis active in the conversion of [14C]penicillin G to [14C]phenylacetylglycine. (1979) (18)
Structure of class I and class II HLA antigens. (1987) (18)
Formation of 5,5-dimethyl-delta2-thiazoline-4-carboxylic acid during cleavage of penicillin G by D-alanine carboxypeptidase from Bacillus stearothermophilus. (1976) (17)
Structural nature of the interaction between T lymphocyte surface molecule CD4 and the intracellular protein tyrosine kinase Ick (1990) (17)
Purification and sequencing of the active site tryptic peptide from penicillin-binding protein 1b of Escherichia coli. (1985) (17)
Regulation of the class II-associated invariant chain gene in normal and mutant B lymphocytes. (1990) (17)
The ins and outs of MHC class II proteins in dendritic cells. (2006) (17)
A simple reverse transcriptase PCR assay to distinguish EBNA1 gene transcripts associated with type I and II latency from those arising during induction of the viral lytic cycle (1996) (17)
N-linked carbohydrate on human leukocyte antigen-C and recognition by natural killer cell inhibitory receptors. (2000) (17)
The Structure of Products of the Major Histocompatibility Complex in Man (1976) (17)
Definition of polymorphic residues on killer Ig‐like receptor proteins which contribute to the HLA‐C binding site (2000) (17)
Cell-free synthesis and processing of the heavy and light chains of HLA-DR antigens. (1980) (17)
Inhibition of experimental autoimmune uveitis by amino acid copolymers (2009) (17)
Cytokinins. Activity and identification in Staphylococcus epidermidis transfer ribonucleic acid. (1970) (16)
Microbial uridine-5'-pyrophosphate N-acetylamino sugar compounds. II. Incorporation of uracil-2-C14 into nucleotide and nucleic acid. (1957) (16)
Rabbit anti-HL-A2 sera. (1975) (16)
Enzymatic synthesis of cytidine diphosphate ascarylose. (1964) (16)
Synthesis of Viosamine (4-Amino-4,6-dideoxy-D-glucose) by Double Inversion at C-4 and Identification with the 4-Amino-4,6-dideoxyhexose from Escherichia coli Strain B (1964) (16)
THYMIDINE DIPHOSPHATE-l-RHAMNOSE METABOLISM IN SMOOTH AND ROUGH STRAINS OF ESCHERICHIA COLI AND SALMONELLA WESLACO (1963) (16)
Interaction of penicillin with its receptors in bacterial membranes (1980) (16)
Positioning of autoimmune TCR-Ob.2F3 and TCR-Ob.3D1 on the MBP85–99/HLA-DR2 complex (2008) (16)
Kinetic evidence for an acyl-enzyme intermediate in D-alanine carboxypeptidases of Bacillus subtilis and Bacillus stearothermophilus. (1977) (16)
Serologic and structural studies of DR-related antigens. (1979) (16)
Immunological and chemical purity of papain-solubilized HL-A antigens. (1975) (16)
The regulatory gene, hXBP-1, and its target, HLA-DRA, utilize both common and distinct regulatory elements and protein complexes. (1993) (16)
[58] Formation of UDP-acetylmuramyl peptides (1966) (15)
Identification of three class II antigens, DR7, MB2, and MT3, from a homozygous human cell line. (1984) (15)
Mutational Analysis of the Structure and Function of the CD4 Protein (1989) (15)
Cosmid clones in the HLA-DZ and -DP subregions. (1990) (15)
Characterization of the 4-acetamido-4,6-dideoxyhexoses from Escherichia coli strains. (1973) (15)
High molecular weight antigens present on human T cells. (1980) (15)
Cortex content of asporogenous mutants of Bacillus subtilis (1976) (15)
Genes for the tumor necrosis factors a and 1 are linked to the human major histocompatibility complex (1999) (15)
The pyridine nucleotide requirement of thymidine diphosphate D-glucose and cytidine diphosphate D-glucose oxidoreductases. (1964) (14)
Partial Purification and Some Properties of the Uridine Diphospho-N-Acetylglucosamine-Enolpyruvate Reductase from Staphylococcus epidermidis (1973) (14)
d-Alanine Carboxypeptidase and Cell Wall Cross-Linking in Bacillus subtilis (1974) (14)
Enzymatic synthesis of cytidine diphosphate 3,6-dideoxyhexoses. V. Partial purification of the two protein components required for introduction of the 3-deoxy group. (1969) (14)
Human histocompatibility antigen mutants immunoselected in vitro. Biochemical analysis of a mutant which synthesizes an altered HLA-A2 heavy chain. (1982) (14)
Relations Between β-Lactamases and Penicillin-Binding Proteins: β-Lactamase Activity of Penicillin-Binding Protein 5 from Escherichia coli (1988) (14)
Further studies of the D-aspartic acid-activating enzyme of Streptococcus faecalis and its attachment to the membrane. (1972) (14)
Interactions of CD4 with MHC class II molecules, T cell receptors and p56lck. (1993) (14)
Reversible 2-epimerization of CDP-paratose and CDP-tyvelose. (1965) (14)
HLA-A*0201 complexes with two 10-Mer peptides differing at the P2 anchor residue have distinct refolding kinetics. (1995) (14)
Detection of HLA‐DP serological allodeterminants by the use of radioiodinated DP molecules (1987) (14)
Use of the HLA-DR antigens incorporated into liposomes to generate HLA-DR specific cytotoxic T lymphocytes. (1984) (14)
Activation of transcription by binding of NF-E1 (YY1) to a newly identified element in the first exon of the human DR alpha gene. (1995) (14)
Inhibition of the Bacillus subtilis Membrane-Bound d-Alanine Carboxypeptidase by 6-Aminopenicillanic Acid Covalently Coupled to Sepharose (1974) (13)
Partial Purification and Properties of the Pyruvate-Uridine Diphospho-N-Acetylglucosamine Transferase from Staphylococcus epidermidis (1973) (13)
Characterization, by immunoprecipitation, of myeloid- and monocyte-specific antigens present on the human promyelocytic cell line (HL-60) in three stages of differentiation. (1981) (13)
Human decidual lymphocytes and the immunobiology of pregnancy. (2004) (13)
Cellular heterogeneity in the thymus. II. Distribution patterns of different lymphocyte populations in chickens (1972) (13)
Biosynthesis and cross-linking of the gamma-glutamylglycine-containing peptidoglycan of vegetative cells of Sporosarcina ureae. (1974) (13)
[83] Glycopeptide synthesis in Staphylococcus aureus and Micrococcus lysodeikticus (1966) (13)
Human T lymphocyte surface antigens: partial purification and characterization utilizing a high-titer heteroantiserum. (1980) (13)
Limited proteolysis of the penicillin-sensitive D-alanine carboxypeptidase purified from Bacillus subtilis membranes. Active water-soluble fragments generated by cleavage of a COOH-terminal membrane anchor. (1981) (13)
Nomenclature for factors of theHLA system, 1991 (1992) (13)
Enzymatic synthesis of the peptide in a uridine nucleotide from Staphylococcus aureus. (1960) (13)
DNA restriction fragment length polymorphism of HLA-DR2: Correlation with HLA-DR2-associated functions (1986) (13)
Conditional spore cortex-less mutants of Bacillus sphaericus 9602. (1976) (13)
Purification and sequencing of the active site tryptic peptide from penicillin-binding protein 5 from the dacA mutant strain of Escherichia coli (TMRL 1222). (1985) (12)
Covalent affinity chromatography of penicillin-binding components from bacterial membranes. (1974) (12)
Glycerol diphosphate disaccharide-pentapeptide: a functional group of the lipid intermediate in cell wall glycopeptide synthesis. (1965) (12)
BIOCHEMISTRY OF THE CELL WALL OF STAPHYLOCOCCUS AUREUS * (1965) (12)
The tortuous journey of a biochemist to immunoland and what he found there. (2006) (12)
Physiologic Regulation of Class II Major Histocompatibility Complex Gene Expression (1986) (12)
NOMENCLATURE FOR FACTORS OF THE HLA SYSTEM, 1990 (1991) (12)
The class I and class II proteins of the human major histocompatibility complex (1995) (12)
Regulation of T-cell antigen receptor (TCR) alpha-chain expression by TCR beta-chain transcripts. (1995) (12)
Free Heavy Chains of HLA-B2705 on the Cell Surface (2002) (12)
Macrophage-Specific Chemokines Induced via Innate Immunity by Amino Acid Copolymers and Their Role in EAE (2011) (12)
Localization of the disulfide bridges of human histocompatibility antigens. (1979) (12)
Enzymatic synthesis of cytidine diphosphate 3,6-dideoxyhexosis. IX. Purification and properties of the cytidine diphosphate-D-glucose pyrophosphorylase from Pasteurella pseudotuberculosis. type V. (1974) (12)
Decidual NK cells kill Zika virus–infected trophoblasts (2021) (12)
High-molecular-weight penicillin-binding proteins from membranes of bacilli (1981) (12)
Biotinylation of class I MHC molecules abrogates recognition by W6/32 antibody. (1999) (12)
Immunological Identity of the Small Subunit of HLA Antigens and $ 2-Microglobulin and Its Turnover on the Cell Membrane ( immunoglobulins / lymphocytes / histocompatibility ) (12)
[Alpha genes of the T cell receptor: a possible implication in genetic susceptibility to multiple sclerosis]. (1987) (12)
The HLA-DQ beta gene upstream region contains an immunoglobulin-like octamer motif that binds cell-type specific nuclear factors. (1987) (12)
Perfusion chromatography for very rapid purification of class I and II MHC proteins. (2000) (12)
Transfected human B lymphoblastoid cells express the mouse Ad beta-chain in association with DR alpha. (1986) (12)
Selective steady-state and time-resolved fluorescence spectroscopy of an HLA-A2-peptide complex. (1995) (11)
The Relationship between Early T Cell Activation Antigens and T Cell Proliferation (1983) (11)
Staphylococcal transfer ribonucleic acids. I. Isolation and purification of the isoaccepting glycine transfer ribonucleic acids from Staphylococcus epidermidis Texas 26. (1974) (11)
Noncanonical Valpha24JalphaQ T cells with conservative alpha chain CDR3 region amino acid substitutions are restricted by CD1d. (1999) (11)
Translocation of a hydrocarbon fluorescent probe between Epstein-Barr virus and lymphoid cells: an assay for early events in viral infection. (1978) (11)
Enzymatic synthesis of the peptide in bacterial ridine nucleotides. V. Co ++ -dependent reversal of peptide bond formation. (1973) (11)
Interferon y response region in the promoter of the human DPA gene (11)
Uridine diphosphate as the sole uridine nucleotide product of hyaluronic acid synthetase in group A streptococci. (1967) (10)
Structural polymorphism of the DC1 light chains from DR1-, DR2-, and DRw6-positive cell lines (2004) (10)
Isolation and characterization of -1,4-N-acetylmuramyl-N-acetylglucosamine and its O-acetyl derivative. (1971) (10)
Solubilization and partial purification of lymphocyte specific antigens in the chicken (1972) (10)
Association of polymorphisms in the HLA-B region with extended haplotypes (2004) (10)
INHIBITION OF CELL WALL SYNTHESIS BY THE ANTIBIOTICS DIUMYCIN AND JANIEMYCIN (1974) (10)
Human T-cell receptor (TCR) alpha/beta + CD4-CD8- T cells express oligoclonal TCRs, share junctional motifs across TCR V beta-gene families, and phenotypically resemble memory T cells. (1993) (10)
Amino acid sequence homologies between Escherichia coli penicillin‐binding protein 5 and class a β‐lactamases (1982) (10)
Photophysical analysis of class I major histocompatibility complex protein assembly using a xanthene-derivatized beta2-microglobulin. (1999) (10)
Purification of penicillin-binding protein 2 of Escherichia coli (1981) (10)
Crystallization and preliminary X‐ray diffraction studies of the human major histocompatibility antigen HLA‐B27 (1992) (10)
The universal donor stem cell: removing the immune barrier to transplantation using CRISPR/Cas9 (TRAN1P.946) (2015) (10)
T cell receptors in an IL-10-secreting amino acid copolymer-specific regulatory T cell line that mediates bystander immunosuppression (2009) (10)
Human T-cell gamma genes contain N segments and have marked junctional variability. (1986) (10)
Enzymatic Reactions in Bacterial Cell Wall Synthesis Sensitive to Penicillins, Cephalosporins, and Other Antibacterial Agents (1967) (9)
Nomenclature for factors of the HLA system, 2004. (2005) (9)
Amino Acid Copolymers That Alleviate Experimental Autoimmune Encephalomyelitis In Vivo Interact with Heparan Sulfates and Glycoprotein 96 in APCs (2013) (9)
Interaction of particle-bound [125I]C3b, the third component of complement, with specific receptors on human B-lymphoblastoid cells (Raji). (1981) (9)
Mode of Action of Penicillin (1945) (9)
Plasmid DNA encoding targeted naturally processed peptides generates protective cytotoxic T lymphocyte responses in immunized animals. (1998) (9)
C4B gene polymorphism detected in a human cosmid clone (2004) (9)
The preparation of uridine diphosphoacetyl-galactosamine. (1959) (9)
THE ROLE OF POLYISOPRENYL ALCOHOLS IN THE BIOSYNTHESIS OF THE PEPTIDOGLYCAN OF BACTERIAL CELL WALLS AND OTHER COMPLEX POLYSACCHARIDES (1972) (9)
An Alternative Path for Antigen Presentation: Group 1 CD1 Proteins (2010) (9)
Interaction of penicillin with the bacterial cell: penicillin-binding proteins and penicillin-sensitive enzymes (1974) (9)
Restriction fragment length polymorphisms and an HLA-DRw52-associated split. (1988) (8)
Isolation from E. coli of a Uridine Nucleotide Containing Diaminopimelic Acid (1958) (8)
Structure and evolution of the HLA Class II SXβ gene (2004) (8)
Interferon-γ response region in the promoter of the class II MHC gene, DPA (1992) (8)
Association of four HLA class III region genomic markers with HLA haplotypes. (1991) (8)
Purification and Properties of the Adenosine Diphosphoglucose:Glycogen Transglucosylase of Pasteurella pseudotuberculosis (1973) (8)
The complete primary structure of the T -Cell receptor genes from an alloreactive cytotoxic human T-lymphocyte clone (2004) (8)
Introducting of the 3-deoxy group in 3,6-dideoxyhexoses: a novel cofactor function for pyridoxamine-5'-phosphate. (1972) (8)
DNA sequences near a meiotic recombinational breakpoint within the human HLA-DQ region (2004) (8)
EPIMERIZATION OF THYMIDINE DIPHOSPHATE GLUCOSE IN BACTERIAL EXTRACTS (1963) (7)
Regulation of dendritic cell subsets by NKT cells. (2003) (7)
Dissection of distinct human immunoregulatory T-cell subsets by a monoclonal antibody recognizing a cell surface antigen with wide tissue distribution. (1981) (7)
Interaction between CD4 and class II MHC molecules mediates cell adhesion. 1987. (2010) (7)
[33] C55-isoprenyl pyrophosphate☆ (1972) (7)
Human class II MHC molecule HLA-DR1: X-ray structure determined from three crystal forms. (1995) (7)
Surface carbohydrate composition of different types of chicken lymphocytes. (1975) (7)
Isolation and structure of HLA antigens. (1978) (7)
The role of dendritic cells in the generation of CD4(+) CD25(HI) Foxp3(+) T cells induced by amino acid copolymers. (2013) (7)
Cooperativity between the J and S elements of class II major histocompatibility complex genes as enhancers in normal and class II- negative patient and mutant B cell lines (1995) (7)
C55-isoprenoid alcohol phosphokinase: an enzyme soluble in organic solvents. (1974) (7)
ELF3 activated by a superenhancer and an autoregulatory feedback loop is required for high-level HLA-C expression on extravillous trophoblasts (2021) (6)
A minimum of four human class II alpha-chain genes are encoded in the HLA region of chromosome 6. (1983) (6)
Antibody to the d-Alanine Carboxypeptidase of Bacillus subtilis Does Not Cross-React with Other Penicillin-Binding Proteins (1977) (6)
Isolation of thymidine diphosphate D-glucose, thymidine diphosphate D-galactose, and thymidine diphosphate 4-acetamido-4, 6-dideoxy-D-galactose from Pasteurella pseudotuberculosis (1967) (6)
Synthesis of 3,6-dideoxy-D-erythro-hexos-4-ulose and identification as the 3,6-dideoxy-4-ketohexose from Pasteurella pseudotuberculosis. (1973) (6)
STEPWISE DEVELOPMENT OF RESISTANCE TO D-CYCLOSERINE IN STAPHYLOCOCCUS AUREUS. (1964) (6)
Restriction fragment length polymorphism (RFLP) of two HLA-B-associated transcripts (BATs) genes in healthy Danes. (1990) (6)
A gamma delta+ T-cell leukemia bearing a novel t(8;14)(q24;q11) translocation demonstrates spontaneous in vitro natural killer-like activity. (1992) (6)
Human major histocompatibility complex genes: class I antigens and tumor necrosis factors. (1986) (6)
Synthesis of linear and comb‐like peptide constructs containing up to four copies of a T cell epitope and their capacity to stimulate T cells (2001) (6)
Structural aspects of the products of the human major histocompatibility complex. (1977) (6)
Relations between beta-lactamases and penicillin-binding proteins: beta-lactamase activity of penicillin-binding protein 5 from Escherichia coli. (1988) (6)
Isolation of 4-O-beta-N-acetylmuramyl-N-acetylglucosamine and 4-O-beta-N, 6-O-diacetylmuramyl-N-acetylglucosamine and the structure of the cell wall polysaccharide of Staphylococcus aureus. (1966) (6)
Simultaneous release of penicilloic acid and phenylacetyl glycine by penicillin-binding proteins 5 and 6 of Escherichia coli (1984) (6)
Pillars article: three-dimensional structure of the human class II histocompatibility antigen HLA-DR1. Nature. 1993. 364: 33-39. (2015) (5)
Inter-Locus and intea-allelic polymorphisms of HLA class I antigen gene mRNA (2004) (5)
Enzymatic addition of lysine to a uridine nucleotide. (1960) (5)
The actions of penicillin and other antibiotics on bacterial cell wall synthesis. (1973) (5)
Cell-surface expression of H-2Db requires N-linked glycans (2004) (5)
Enzymatic Sulfation of Mucopolysaccharides in Hen Oviduct (2003) (5)
Studies of expression of the DQ beta promoter and its 5' deletion derivatives in normal and mutant human B cell lines. (1989) (5)
L cells expressing DQ molecules of the DR3 and DR4 haplotypes: reactivity patterns with mAbs (2004) (5)
Early Events in Transformation of Human Lymphocytes by the Virus (1979) (5)
Human Fetal Liver ' y / ~ T Cells Predominantly Use Unusual Rearrangements of the T Cell Receptor and " y Loci Expressed on Both CD 4 + CD 8-and C D 4C D 8-T Cells (2003) (5)
Differential Responses of Invariant Vα24JαQ T Cells and MHC Class II-Restricted CD4+ T Cells to Dexamethasone (1999) (5)
Cellular Heterogeneity in the Thymus: Graft-versus-Host Activity of Fractionated Thymus Cells in the Chicken 1 (1973) (5)
Sedimentation Characteristics of Newly Synthesized Epstein-Barr Viral DNA in Superinfected Cells (1981) (5)
Penicillin Binding Components in Bacillius subtilis During Sporulation (1974) (5)
Detergent-soluble products of the HLA region. (1977) (4)
Electron microscope studies of conditional spore cortexless mutants of Bacillus sphaericus (1976) (4)
Genomic organization of the human T-cell antigen-receptor a/S locus (4)
Molecular Characterization of Serologic Recognition Sites in the HLA-A2 Molecule Using Oligonucleotide-Generated Site-Specific Mutants (1989) (4)
Structure and evolution of the HLA class II SX beta gene. (1986) (4)
Enzymatic dephosphorylation of C 55 -isoprenylphosphate. (1972) (4)
Non—MHC—restricted target—cell lysis by a CD4−CD− TCRαβ T—cell line, as well as by TCR4gMδ T—cell lines, results from lymphokine—activated killing (2007) (4)
Sequence of human beta 2-microglobulin: a correction. (1982) (4)
T-cell receptor gene rearrangement and expression in human natural killer cells: natural killer activity is not dependent on the rearrangement and expression of T-cell receptor α, β, or γ genes (2004) (4)
Biochemical Studies oftheSmooth-Rough Mutation inSalmonella minnesota (1965) (4)
Effects of Penicillin on Bacterial Cell Wall Synthesis in E. coli and in S. aureus (1958) (4)
[56] Formation of CDP-3,6-dideoxyhexoses from CDP-d-glucose (1966) (4)
HUMi\N CLASS II MAJOR HIST()COMP ATIBILITY COMPLEX GENES AND PROTEINS (1988) (4)
Peptide vaccination against cancer? (1995) (4)
A novel method for generating stable high-level transfectants involving direct immunomagnetic selection for cell-surface epitopes: expression of HLA class-II genes in HeLa cells. (1991) (4)
Nucleotide intermediates in the biosynthesis of polysaccharides. (1962) (4)
A highly divergedβ1 exon in theDR region of the human MHC: Sequence and evolutionary implications (2004) (4)
CD1 Antigen Presentation and Autoreactivity in the Pregnant Human Uterus (2015) (4)
Novel subsets of human T cells (CD4+ CD8+ TCRγδ and CD4− CD8− TCRαβ) and T‐cell development (1989) (4)
A monoclonal antibody that recognizes the alpha chain of HLA-DR antigens. (1986) (4)
Induction of several new antigens, including a T cell-associated antigen, following conversion of the EBV-negative B cell line RAMOS to EHRB-RAMOS by Epstein-Barr virus. (1981) (4)
An HLA DRw52 Split Defined by Restriction Fragment Length Polymorphism: Population Genetics in Normals and in an HLA DRw52 Associated Autoimmune Disease (1989) (4)
The Human Major Histocompatibility Complex Genes and Proteins a (1985) (4)
The autoimmune TCR-Ob.2F3 can bind to MBP85-99/HLA-DR2 having an unconventional mode as in TCR-Ob.1A12. (2010) (4)
CHARACTERIZATION OF A THIRD FORM OF THE HUMAN T CELL RECEPTOR y/S (2003) (4)
Comparison of orthorhombic and monoclinic crystal structures of HLA-A2. (1989) (3)
Genetically modified hematopoietic stem/progenitor cells that produce IL-10–secreting regulatory T cells (2019) (3)
Chapter 4 Complete Primary Structure of Human Histocompatibility Antigen Hla-B7: Evolutionary and Functional Implications (1980) (3)
MICRODETERMINATION OF URIDINE DIPHOSPHATE GLUCOSE PYROPHOSPHORYLASE IN BRAIN * (1961) (3)
Analysis of human class II antigen α chain genes: a summary (1983) (3)
Rapid purification of detergent-solubilized HLA antigen by affinity chromatography employing anti-beta2-microglobulin serum. (1976) (3)
ISOLATION AND STRUCTURE OF PRODUCTS OF THE HUMAN HISTOCOMPATIBILITY GENE COMPLEX (1976) (3)
Human Histocompatibility Antigens: Genes and Proteins (1984) (3)
Role of Polyisoprenyl Alcohols in the Biosynthesis of Complex Polysaccharides (1973) (3)
Don Craig Wiley (1944–2001): a reminiscence (2002) (3)
Nomenclature for factors of the HLA system, 2000. (2001) (3)
The immunoglobulin-like structure of human histocompatibility antigens. (1976) (3)
T-cell receptor gene rearrangement and expression in human natural killer cells: natural killer activity is not dependent on the rearrangement and expression of T-cell receptor alpha, beta, or gamma genes. (1988) (3)
Molecular Involvement of the pvt-1 Locus in a y/8 T-Cell Leukemia Bearing a Variant t(8;14)(q24;qll) Translocation (2)
INTERACTIONS BETWEEN PEPTIDE AND CLASS-I MHC - IMPLICATIONS FOR IMMUNOTHERAPY IN RHEUMATIC DISEASE (1993) (2)
Non-MHC-restricted target-cell lysis by a CD4-CD8- TCR alpha beta T-cell line, as well as by TCR gamma delta T-cell lines, results from lymphokine-activated killing. (1991) (2)
Decidual endothelium, Notch1 and TGFβ, gatekeepers for Treg accumulation at the maternal–fetal interface (2016) (2)
[95] d-Aspartic acid activating enzyme (Streptococcus faecalis) (1970) (2)
Immunochemistry of the HLA class II molecules isolated from a mouse cell transfected with DQ alpha and beta genes from a DR4 haplotype (2004) (2)
Nomenclature for factors of the HLA system, 1995, update June 1995 (1995) (2)
Trapping of the substrate-derived acyl enzyme intermediate of purified penicillin-binding protein 1a of Escherichia coli (1984) (2)
NH2-terminal sequence of the α and β chains of human DC-1 antigen isolated from the JY cell line. Homology with murine I-A molecules (2004) (2)
Penicillin-binding proteins of bacteria. (1977) (2)
MONOMERIC RECOMBINANT MD-2 BINDS TLR4 TIGHTLY AND CONFERS LPS RESPONSIVENESS (2002) (2)
STUDIES OF THE STRUCTURE OF THE HUMAN Ia-LIKE ANTIGEN (1978) (2)
[57] Formation of TDP-4-acetamido-4,6-dideoxyhexoses from TDP-d-glucose (1966) (2)
Nomenclature for factors of the HLA System, 1998. (1999) (2)
[87] Peptidoglycan transpeptidase in Bacillus megaterium (1972) (2)
O821 - Definition of antigenic determinants on glutamic acid decarboxylase molecule in HLA-DQ transgenic mice (1996) (2)
A National Science Foundation (1948) (2)
Correction: Extreme Th1 bias of invariant Vα24JαQ T cells in type 1 diabetes (1999) (2)
The 1995 Albert Lasker Medical Research Award. The class I and class II proteins of the human major histocompatibility complex. (1995) (2)
Nomenclature for factors of the HLA system, 1990. The WHO Nomenclature Committee for factors of the HLA system. (1991) (2)
Enzymes of Bacterial Cell Wall Synthesis as Components of the Cell Membrane (1971) (2)
Amino acid sequence homologies between Escherichia coli penicillin-binding protein 5 and class A beta-lactamases. (1982) (2)
Molecular Characterization of Allospecific Cytotoxic T-Lymphocyte Recognition Sites in the HLA-A2 Molecule Using Oligonucleotide-Generated Site-Specific Mutants (1989) (2)
An essential function for b-arrestin 2 in the inhibitory signaling of natural killer cells (2008) (2)
Nomenclature for factors of the HLA system, 1996. (1997) (2)
Cytotoxic T cells directed against HLA-DR antigens and their surface proteins. (1983) (1)
Analysis of the DRβ chains from two DRw6 cell lines (WT46 and WT52): Recombination in vivo may have generated new haplotypes (2004) (1)
INHIBITION OF DNA SYNTHESIS IN EHRLICH ASCITES CELLS BY ACTINOMYCIN D, THE PRESYNTHETIC BLOCK IN THE CELL CYCLE* (1)
Mutants of HLA-A2 in the analysis of its structure and function. (1989) (1)
Developmental biology of T cells expressing the γδ T-cell receptor (1990) (1)
Nomenclature for factors of the HLA system, 2002. (2002) (1)
Complete Primary Structure of Human Histocompatibility Antigen HLA-B7 (1981) (1)
HUMAN HISTOCOMPATIBILITY ANTIGENS (1981) (1)
Partial Purification of Detergent-Soluble HLA Antigen and Its Cleavage by Papain ( 82-microglobulin / Brij 9 / histocompatibility ) (1)
Use of monoclonal antibody immunoaffinity columns to purify subsets of human HLA-DR antigens. (1984) (1)
A Human Cytotoxic Lymphocyte Subdividing the DQ1 Antigen (2004) (1)
Sedimentation characteristics of newly synthesized Epstein-Barr viral DNA in superinfected cells (1981) (1)
Using DNA chips to unravel the genetics of type 1 diabetes. (2000) (1)
Heavy chain of HLA-A and HLA-B antigens is conformationally labile : A possible role for f 32-microglobulin ( histocompatibility antigens / circular dichroism / fl-pleated sheet / chain association ) (1)
Cloning and sequence analysis of complementary DNA encoding an aberrantly rearranged human T-cell y chain (2003) (1)
Chemical basis for the immunological specificity of a strain of Staphylococcus aureus. (1960) (1)
PENICILLIN BINDING PROTEINS AS TARGETS OF THE LETHAL EFFECTS OF β-LACTAM ANTIBIOTICS (1983) (1)
A highly diverged beta 1 exon in the DR region of the human MHC: sequence and evolutionary implications. (1987) (1)
III. PURIFICATION AND PROPERTIES OF THYMIDINE DIPHOSPHATE 4-KETO-6-DEOXY-D-GLUCOSE TRANSAMINASE FROM ESCHERICHIA COLI STRAIN B* (1966) (1)
Double-negative ( CD 4-CD 8-) lymphocytes bearing T-cell receptor a and f 3 chains in normal human skin ( CD 4-CD 8-TCRaP lymphocytes / human (1)
Perspectives and priorities (2002) (1)
The Bactericidal Mechanisms of Antibiotic Drugs (1967) (1)
SYNTHESIS OF 3,6-DIDEOXY-D-ERYTHRO-HEXOS-4-ULOSE AND IDENTIFICATION AS THE 3,6-DIDEOXY-4-KETOHEXOSE FROM PASTEURELLA PSEUDOTUBERCULOSIS (1973) (1)
Structural and sequence homologies between HLA-A and HLA-B antigens and immunoglobulins. (1979) (1)
Pillars Article: Identification of a Putative Second T-cell Receptor. Nature. 1986. 322: 145-149. (2016) (1)
Molecular anatomy of immune recognition: How peptides bind to class I MHC molecules (1991) (1)
Biochemical Effects of Novo-biocin on Staphylococcus aureus. (1965) (1)
T 3 glycoprotein is functional although structurally distinct on human T-cell receptor y T lymphocytes ( activation / antigen receptor / glycosylation / intracellular calcium / phosphorylation ) (1)
The shape-maintaining component of halobacterium salinarium: a cell surface glycoprotein. (1977) (1)
Structural studies of the membrane-associated products of the human major histocompatibility complex. (1980) (1)
Perforin-low decidual CD8+T cells are fully functional upon stimulation (2016) (1)
[On the immunochemistry of O antigens of Enterobacteriaceae. VII. The relation of hexoses and 6-desoxyhexoses in Salmonella lipopolysaccharides to the D and L group]. (1962) (1)
ASHI conference, Vancouver, Canada, October 10th, 1998 (1999) (1)
Analysis of human class II antigen alpha chain genes: a summary. (1983) (1)
Proceedings: The structure of products of the major histocompatibility complex. (1976) (1)
Lymphocytes: Null Cells That Modulate H-2 (1977) (1)
COMPLEX OF THE HUMAN MHC CLASS II GLYCOPROTEIN HLA-DR1 AND THE BACTERIAL SUPERANTIGEN SEB (1996) (1)
9.7-03 Association of four class III genomic markers mapping near TNF with extended HLA-A-B-DR haplotypes (1989) (1)
Microbial Surfaces Microbial Cell Walls and Membranes H. J. Rogers H. R. Perkins J. B. Ward (1982) (1)
Novel subsets of human T cells (CD4+ CD8- TCR gamma delta and CD4- CD8- TCR alpha beta) and T-cell development. (1989) (1)
Isolation of C 55 -isoprenylpyrophosphate from micrococcus lysodeikticus. (1972) (1)
Sequence Analysis of the Human Major Histocompatibility Gene SXa (2003) (1)
NH2-terminal sequence of the alpha and beta chains of human DC-1 antigen isolated from the JY cell line. Homology with murine I-A molecules. (1983) (1)
S U P P R E S S I O N OF IN VITRO EPSTEIN-BARR VIRUS INFECTION A New Role for Adult Human T Lymphocytes* BY DAVID A. THORLEY-LAWSON, LEONARD CHESS, AND JACK L. STROMINGER (2003) (0)
Comparison of Amino Acid Copolymers Glatiramer Acetate (GA) and poly(Y, F, A, K)n in Inhibition of Development of Experimental Autoimmune Uveitis (EAU) and Related Immune Responses (2008) (0)
Uridine diphosphoglucose (UDPG) (2014) (0)
Are YFAK-specific TCR retrogenic mice whose splenocytes secrete high levels of IL-10 protected from EAE? (56.9) (2012) (0)
Structural and Functional Analysis of Human Class I and Class II Major Histocompatibility Complex Proteins, with Special Emphasis on Alloreactivity (1989) (0)
Peptide independent assembly of HLA-DR2 molecules from subunits expressed in E. coli (1994) (0)
Players in Innate Immunity Animal Antimicrobial Peptides: Ancient (2009) (0)
Binding ofsoluble natural ligands toasoluble humanT-cell receptor fragment produced inEscherichia coli (1994) (0)
in NK cytoskeleton organization and activation Dendritic cell and natural killer cell cross-talk: a pivotal role of CX3CL1 (2013) (0)
Fusion proteins of MHC class II, soluble, monovalent or polyvalent, and their uses. (1997) (0)
Crystal structure of HLA-DQ0602 in complex with a hypocretin peptide (2004) (0)
Class II MHC molecules are receptors for sperm (1989) (0)
Comparison ofaminoacidsequences oftwohuman histocompatibili ty antigens, HLA-A2andHLA-B7: Location ofputative alloantigenic sites (1979) (0)
Changes in Lysosomal MIIC Differentiation Accompanies Structural MHC Proteins during Myeloid Dendritic Cell Conformational Variation of Surface Class II (2005) (0)
METHODS FOR MEASURING INHIBITION BY D-CYCLOSERINE OF ENZYMATIC REACTIONS ESSENTIAL FOR BACTERIAL CELL WALL SYNTHESIS. (1964) (0)
Immunological Identity oftheSmallSubunit ofHL-AAntigens and $2-Microglobulin andItsTurnover ontheCellMembrane (1974) (0)
Long-range chromatin interactions control trophoblast-restricted HLA-G expression during pregnancy (IRM6P.657) (2015) (0)
STUDIES IN STAPHYLOCOCCUS AUREUS IN VIVO OF CROSS-LINKING BY PENICILLINS AND CEPHALOSPORINS : Biosynthesis of the Peptidoglycan of Bacterial Cell Walls : XII (2003) (0)
Gene organization of DC and DX si histocompatibility complex (gene sequences/promoters/DNA-DNA hybridization/HLA antigens (2016) (0)
Two Distinct Subsets of Macrophages at the Human Maternal-fetal Interface: Neither Proinflammatory nor Immunosuppressive (2010) (0)
Molecular basis of immune recognition (1987) (0)
Isolation and characterization of the fraction of synthetic copolymer 1 bound to recombinant HLA-DR Molecules (1998) (0)
Frontmatter (1983) (0)
ENZYMATIC FORMATION OF URIDINE (2003) (0)
Comparison of the Secondary Structures of Human Class I and Class II MHC Antigens by Ftir and CD Spectroscopy (1989) (0)
Letter from Jack L. Strominger to Joshua and Esther Lederberg (1958) (0)
KIR2DS1+ decidual natural killer cells show ex-vivo activation and cytotoxicity but not cytokine secretion (MUC7P.756) (2014) (0)
nes allospecific for (2016) (0)
Pillars Article: Three-Dimensional Structure of a Human Class II Histocompatibility Molecule Complexed with Superantigen. Nature. 1994. 368: 711-718. (2018) (0)
Human T-cell receptor ( TCR ) a / , 8 + CD 4-CD 8-T cells express oligoclonal TCRs , share junctional motifs across TCR Vp-gene families , and phenotypically resemble memory T cells (2005) (0)
NK3-specific natural killer cells are selectively inhibited by BW4 Positive HLA alleles with isoleucine 80 (1994) (0)
patient andmutantB-cell lines represent atleast three, andprobably four, distinct genetic defects defined bycomplementation analysis (1991) (0)
Human HLA-G+ extravillous trophoblasts: immune activating cells that interact with decidual leucocytes (MUC2P.921) (2015) (0)
Cloning and sequence analysis of the human major histocompatibility complex gene DC-3 f 3 ( class II antigen / Southern blot analysis ) (1999) (0)
Complete primary structure of human histocompatibility antigen HLA-B7: evolutionary and functional implications. (1980) (0)
EosinophilsCostimulatory Activity in Human IL-3 Induces B 7 . 2 ( CD 86 ) Expression and (2001) (0)
BACI TRACIN: AN INHIBITOR OF THE DEPHOSPHORYLATION OF LIPID PYROPHOSPHATE, AN INTERMEDIATE IN BIOSYNTHESIS OF THE PEPTIDOGLYCAN OF BACTERIAL CELL WALLS* (2004) (0)
Letter from Jack L. Strominger to Joshua Lederberg (1958) (0)
Developmental biology of T cells expressing the gamma delta T-cell receptor. (1990) (0)
Long-term human cytolytic T-cell lines allospecific for HLA-DR 6 antigen are OKT 4 ' ( cytotoxic T lymphocyte / DR specificity / surface antigens ) (0)
Variant and Mutant HLA-A2 Molecules Affect Recognition of Influenza Matrix Peptide 56–68 by Cytotoxic T Lymphocytes (1989) (0)
Enzymic Removal and Re-expression of a at the Surface of Human Peripheral Lym) (2016) (0)
DEMONSTRATION OF S T R U C T U R A L P O L Y M O R P H I S M AMONG HLA-DR LIGHT CHAINS BY TWO-DIMENSIONAL GEL ELECTROPHORESIS* (2003) (0)
[88] d-Alanine carboxypeptidase from Bacillus subtilis☆ (1972) (0)
Partial Purification ofDetergent-Soluble HL-AAntigen andIts Cleavage byPapain (1974) (0)
[74] CDP-ribitol: Acceptor phosphoribitoltransferase from Staphylococcus aureus (1966) (0)
CD11cHI macrophages are specialized APCs in the early human placenta (169.45) (2011) (0)
Crystallographic analysis of endogenous peptides associated with HLA-DR1 suggests a common, polyproline IT-like conformation (2016) (0)
Purification of Complexes between Peptide Antigens and Class II Major Histocompatibility Complex Antigens Using Biotinylated Peptides (1989) (0)
NOMENCLATURE FOR FACTORS OF THE HLA SYSTEM, 1994 (1994) (0)
Proliferation, cytokine secretion, and immunosuppressive activity of YFAK-specific regulatory T cells. (THER3P.885) (2014) (0)
Conformational variants of class II MHCypeptide complexes induced by N- and C-terminal extensions of minimal peptide epitopes (HLA-DRyinvariant chainyhemagglutininypolymer) (1999) (0)
DRUG RESISTANCE IN BACTERIAL CELLS. (1964) (0)
The Epstein-Barr Virus Bam HI F Promoter Is an Early Lytic Promoter : Lack of Correlation with EBNA 1 Gene Transcription in Group 1 Burkitt ’ s Lymphoma Cell Lines (1995) (0)
Antigen Neonatal Microglia That Primes Them for Factor Induces an Expression Program in Granulocyte-Macrophage Colony-Stimulating (2002) (0)
LIPID-PHOSPHOA CETYLMURAM YL-PENTAPEPTIDE AND LIPID-PHOSPHODISACCHARIDE-PENTAPEPTIDE: PRESUMED MEMBRANE TRANSPORT INTERMEDIATES IN CELL WALL SYNTHESIS* (0)
Inhibition of proliferative and plaque-forming cell responses by human bone-marrow-derived lymphocytes from peripheral blood by antisera to the p 23 , 30 antigen ( Ia antigen ) (0)
Human T-cell receptor (TCR) a/,8+ CD4-CD8- T cells express oligoclonal TCRs, share junctional motifs across TCR Vp-gene families, and phenotypically resemble memory T cells (2005) (0)
Molecular analysis of human HLA-G+ trophoblasts reveals their strong immune regulatory potential (P2172) (2013) (0)
The very late antigen family of hete superfamily of molecules involved ii (2016) (0)
[139] Glycyl-tRNA synthetase (Staphylococcus aureus) (1970) (0)
Interferon-gamma response region in the promoter of the class II MHC gene, DPA. (1992) (0)
TREATMENT OF AUTOMMUNE DISEASES (2017) (0)
Comparison of amino acid sequences of two human histocompatibility antigens , HLA-A 2 and HLA-B 7 : Location of putative alloantigenic sites ( protein structure / genetic polymorphism / alloantigenic determinants ) (0)
Human decidual CD8+ effector T cell responses in pregnancy (MUC2P.924) (2015) (0)
Methods for the detection, purification, and biochemical characterization of lymphoid cell surface antigens (1984) (0)
Papain-Solubilized HLA Antigens from Cultured Human Lymphocytes Contain Two Peptide Fragments ( histocompatibility / glycoproteins / membrane / molecular weight ) (1999) (0)
for overlapping mRNAs. Epstein-Barr virus BamHI M fragment: evidence corresponding to a transcript from the Characterization of a cDNA clone (2013) (0)
Immunological and Chemical Purity of Papain-Solubilized HLA Antigens ( radiolabeling / immune complexes / gel filtration / N-terminal amino acids ) (0)
Eosinophils Costimulatory Activity in Human IL-3 Induces B7.2 (CD86) Expression and (2017) (0)
2728 – DRUG-RECEPTOR INTERACTIONS: THE EXAMPLE OF β-LACTAM ANTIBIOTICS (1978) (0)
The Role of Murine Myeloid Cells On Stimulation with Amino Acid Copolymers (2013) (0)
Nomenclature for factors of the HLA system, 2000. (2001) (0)
Amino Acid Sequences in the al Domain and Not Glycosylation Are Important in HLA-A2/32-Microglobulin Association and Cell Surface Expression (0)
RNA polymerases in human lymphoblastoid cells that contain Epstein-Barr virus. (1975) (0)
[12] d-Alanine carboxypeptidases I and II (Escherichia coli) (1970) (0)
26 – Structure–Function Relationship in Human Class I HLA Molecules (1988) (0)
Arthritis-Associated HLA-DR Molecules Sclerosis- and Rheumatoid Binding Motifs of Copolymer 1 to Multiple (1999) (0)
Mechanism for Immune Regulation Q T Cells: A Feedback a 24J a Activity of V Cytokine Secretion from and Cytolytic CD1d on Myeloid Dendritic Cells Stimulates (2000) (0)
Molecular cloning of a complementary dna encoding the heavy chain of the 4f2 cell surface antigen (1987) (0)
Regulation of EAE by spontaneously generated IL‐10‐secreting regulatory T cells in HLA‐DR15/TCR.Ob1A12 double transgenic mice (2021) (0)
Crystallization of the complex of HLA-DR2 with immunodominant myelin basic protein peptide (1998) (0)
Heterogeneity ofHL-AAntigen Preparations IsDueto Variable Sialic AcidContent (1974) (0)
The last role of invariant chain (1993) (0)
cDNA clones for the heavy chain of after immunopurification of polyso (mRNA purification/cDNA cloning/immune response genes/major I (2016) (0)
Mapping of a new genetic locus responsible for ampicillin resistance in Escherichia coli (1976) (0)
[60] The biosynthesis of 3,6-Dideoxy sugars: Formation of CDP-4-keto-3,6-dideoxyglucose from CDP-glucose (1972) (0)
AnEpstein-Barr virus transcript fromalatently infected, growth- transformed B-cell line encodes ahighly repetitive polypeptide (alternative splicing/cDNA cloning/in vitro transcription andtranshgtion/immunoprecipitation) (1986) (0)
HUMAN CELL SURFACE ANTIGENS STUDIED WITH MONOCLONAL ANTIBODIES (1982) (0)
[75] UDP-N-acetylglucosamine: Polyribitol phosphate N-acetylglucosaminyltransferases from Staphylococcus aureus (1966) (0)
Trogocytosis and endocytosis of HLA-G from extravillous trophoblasts by decidual NK cells and its functional consequence (MUC2P.922) (2015) (0)
Malfunction of dendritic cells from aged mice leads to loss of activation of Natural Killer cells (P4353) (2013) (0)
Allospecific natural killer cells are generated by reciprocal stimulation across a diallelic polymorphism of HLA-C (1993) (0)
Identification and mapping of polypeptides encoded by the P 3 HR-1 strain of Epstein-Barr virus ( hybrid selection / cell-free translation / DNA-binding proteins / immunoprecipitations ) (0)
with commitment to the T-cell receptor alpha beta lineage Disruption of the SCL locus in T-lymphoid malignancies correlates (2011) (0)
Calcineurin Mediates H u m a n Tumor Necrosis Factor cr Gene Induction in Stimulated T and B Cells (2003) (0)
Amino acid copolymers that alleviate experimental autoimmune encephalomyelitis (EAE) in vivo interact with heparan sulfates and gp96 in antigen presenting cells (2014) (0)
ORGANIZATION, DIVERSITY AND REARRANGEMENT OF THE HUMAN T-CELL REARRANGING GAMMA-GENES (1986) (0)
Characterization of TCR retrogenic mice that have a YFAK-specific regulatory T cell population. (P5230) (2013) (0)
[83a] Glycopeptide transpeptidase and d-alanine carboxypeptidase in Escherichia coli (1966) (0)
Individual heterogeneity determines the interaction between human dendritic cells and natural killer cells (147.23) (2011) (0)
Cytolytic capacity of KIR2DS1+ decidual natural killer cells in the fetal-maternal interface (P3203) (2013) (0)
Oplöselige monovalent and multivalent MHC Class II fusion proteins, and uses thereof (1997) (0)
LIPID INTERMEDIATE IN PEPTIDOGLYCAN SYNTHESIS crude lipid intermediate in isobutyric acid - (0)
Purification and Characterization of Class I 1 Histocompatibility Antigens from a Homozygous Human B Cell Line (2001) (0)
C55-Isoprenoid Alcohol Phosphokinase: An Intrinsic Membrane Enzyme (1976) (0)
Structure of the major human histocompatibility antigens (HLA-A and HLA-b): evolutionary and functional implications. (1981) (0)
Drug-Receptor Interactions: The Example of β-Lactam Antibiotics* (1979) (0)
Isolation and molecular studies of human HLA-G+ extravillous trophoblasts (EVT) (2010) (0)
Recepteur de lymphocyte t monocatenaire (1995) (0)
Synthetic copolymers and peptides that inhibit binding of the collagen type II 261-273 epitope to rheumatoid arthritis-associated HLA-DR1 and-DR4 molecules and collagen-specific T cell responses. (2000) (0)
A solubilized T-cell receptor from a human leukemia cell line binds to a ligand in the absence of MHC products (2004) (0)
Alanine Carboxypeptidase from Bacillus subtilis Membranes (2002) (0)
The Immunochemistry of the O Antigen of Enterobacteriaceae. VII. The hexoses and 6-desoxy-hexoses in the Lipopolysaccharides of Salmonella. (1962) (0)
Regulation of T-cell antigen receptor (TCR) a-chain expression by TCR ,8-chain transcripts (2005) (0)
ExtremeTh 1 biasof invariant V a 24 J a QTcells in type 1 diabetes (1999) (0)
Novel synthetic amino acid copolymers suppress MBP 85-99-induced EAE in humanised double-transgenic mice through different effects on T cell responses (2004) (0)
A national science foundation. 1948. (2000) (0)
Food Intake and Hypothalamic Hyperphagia † (1953) (0)
Transcriptome analysis reveals similarities between human blood CD3− CD56bright cells and mouse CD127+ innate lymphoid cells (2017) (0)
Rapid detection of mixed lymphocyte culture reactivity by 4F2 antigen appearance as detected by flow cytometry (1982) (0)
Both VAMP4 and VAMP7 are indispensable for NK cell cytotoxicity: the requirement for two R-SNARE proteins in granule exocytosis. (89.24) (2010) (0)
Purification and Characterization of a Prokaryotic Glycoprotein from the Cell Envelope of HaLobacterium saZinarium (2002) (0)
Cloning andsequence analysis ofcomplementary DNA encoding an aberrantly rearranged humanT-cell ychain (1986) (0)
Epstein-Barr virus receptor of human B lymphocytes is the C 3 d receptor CR 2 ( complement / Epstein-Barr virus / monoclonal antibody ) (0)
Adjustment of caloric intake of rats to dietary change. (1948) (0)
DNA synthesis in nuclei isolated from cultured lymphoblastoid cells. (1975) (0)
Cytolytic T lymphocyte recognition of human-mouse hybrid class I molecules (1985) (0)
Two genes encoding steroid 21-hyd genes encoding the fourth componE (congenital adrenal hyperplasia/HLA haplotype/autoimmunity/cytoc (2016) (0)
HLA-DR Region Proteins and Genes* (1983) (0)
APCsHeparan Sulfates and Glycoprotein 96 in Encephalomyelitis In Vivo Interact with Experimental Autoimmune Amino Acid Copolymers That Alleviate (2013) (0)
Dissociation and exchange of the f32-microglobulin subunit of HLA-A and HLA-B antigens (subunit association equilibrium/radioimmunoassay/cell surface probe) (0)
Populations Two Unique Human Decidual Macrophage (2011) (0)
Dendritic Cells Induced by TLR4 or TLR3 in Human of Th1 Cytokines That Are Specifically Stimulation Blocks the Induction of a Subset IL-10 Released by Concomitant TLR2 (2004) (0)
Modification of Ser 59 in the unique N-terminal region of tyrosine kinase p 561 ck regulates specificity of its Src homology 2 domain ( tyrosine phosphorylation / glutathione S-transferase fusion protein / surface plasmon resonance ) (2005) (0)
OR.18. Decidual NK Cells Play a Role in Maternal-fetal Tolerance by Producing Galectin-1 (2008) (0)
Human decidual tissue contains disarmed CD8+ Effector-Memory T cells (48.2) (2010) (0)

This paper list is powered by the following services:

Other Resources About Jack L. Strominger

en.wikipedia.org

What Schools Are Affiliated With Jack L. Strominger?

Jack L. Strominger is affiliated with the following schools:

Jack L. Strominger's Academic­Influence.com Rankings